TruthArchive.ai - Tweets Saved By @Amy31129057
@Amy31129057 - QuestionIt
Pay Attention~ @SpeakerJohnson @Jim_Jordan @RepThomasMassie International Crisis Group (ICG) Robert Malley, who previously served in the Obama administration as a senior adviser, became president and CEO of ICG in January 2018. Malley had his ties to the Obama electoral campaign severed in May 2008, when it became public that Malley had been in discussions with the militant Palestinian group Hamas, listed by the U.S. State Department as a terrorist organization. His predecessors in the position include former UN Under-Secretary-General for Peacekeeping Operations Jean-Marie Guéhenno, former UN High Commissioner for Human Rights and Justice of the Supreme Court of Canada Louise Arbour, and former Foreign Minister of Australia Gareth Evans. Crisis Group is headquartered in Brussels, with advocacy offices in Washington DC, New York and London. Other legally registered offices are based in Bogota, Colombia; Dakar, Senegal; Istanbul, Turkey; and Nairobi, Kenya. As of June 2018, Crisis Group has a presence in Abu Dhabi, Abuja, Bangkok, Beirut, Caracas, Gaza City, Guatemala City, Hong Kong, Jerusalem, Johannesburg, Juba, Kabul, Kiev, Mexico City, Mogadishu, Rabat, Tbilisi, Toronto, Tunis and Yangon. As of September 2023, Crisis Group Board of Trustees has 44 members. Frank Giustra, founder of the Giustra Foundation and Acceso, became co-chair in 2020, and Susana Malcorra, former Foreign Minister of Argentina and former Chef de Cabinet of the UN Secretary-General, joined him as co-chair in 2021. Previously, the board was chaired by Mark Malloch Brown, former UN Deputy Secretary-General and Administrator of the United Nations Development Program. Past board members have included Sandy Berger and Stephen Solarz. Chairmen emeritus are Martti Ahtisaari, George J. Mitchell and Thomas R. Pickering. Gareth Evans remained President Emeritus as of 2023. In 2023, several of ICG's staff members were connected to the Iran Experts Initiative. In Jan. 1993, Mark Malloch-Brown was co-founder, trustee and chairman of International Crisis Group (ICG). Membership included George Soros, George Soros, Alexander Soros, Morton I. Abramowitz (Carnegie Endowment for International Peace), Frank Giustra (Jul. 01, 2006, Clinton Foundation, Clinton Global Initiative), Wesley Clark, Lawrence H. Summers (Harvard, Instagram, Square, Facebook, Sheryl K. Sandberg, Yuri Milner, Alisher Usmanov, http://Mail.ru, Vkontact, Andreessen-Horowitz, National Economic Council (Obama)), Bill Clinton, George H.W. Bush, U.S. State Department, USAID, Open Society Foundation, more. https://en.wikipedia.org/wiki/International_Crisis_Group
@Amy31129057 - QuestionIt
Hey @DecentFiJC is there anything in your findings involving ICG?
@Amy31129057 - QuestionIt
Flashback Friday- The activities of the biological laboratories of the US Department of Defense in Ukraine *52 Pages for those so inclined........ https://files.oprf.ru/storage/image_store/biolab_USA_en_1.pdf https://t.co/xBRV004gqI
@Amy31129057 - QuestionIt
Looks like we have another Genie in the bottle @DecentBackup https://t.co/NRwv6aHCNU
@Amy31129057 - QuestionIt
You have to be kidding me!! Cass Sunstein, husband of Samantha Power (USAID), was appointed as Chair of the World Health Organizations technical advisory group on Behavioral Insights and Sciences for Health!!!! Are you seeing this @elonmusk @DOGE @POTUS @RobertKennedyJr https://thersa.org/events/speakers/cass-sunstein#:~:text=Cass%20R.%20Sunstein%20is%20the,Insights%20and%20Sciences%20for%20Health…
@Amy31129057 - QuestionIt
FYI~ Samantha Power's husband is Cass Sunstein Sunstein joined the Department of Homeland Security in February 2021 as an advisor to the Biden administration on immigration policy. In his book Democracy and the Problem of Free Speech Sunstein says there is a need to reformulate First Amendment law. An American legal scholar known for his work in constitutional law, administrative law, environmental law, and behavioral economics. He was the administrator of the White House Office of Information and Regulatory Affairs in the Obama administration from 2009 to 2012. As a professor at the University of Chicago Law School for 27 years, he wrote influential works on regulatory and constitutional law, among other topics. Since leaving the White House, Sunstein has been the Robert Walmsley University Professor at Harvard Law School. Sunstein graduated magna cum laude with a bachelor of arts from Harvard College in 1975. At Harvard, he was a member of the varsity squash team and an editor of the Harvard Lampoon. In 1978, he graduated magna cum laude with a juris doctor from Harvard Law School, where he was executive editor of the Harvard Civil Rights-Civil Liberties Law Review and was a member of the winning team of the Ames Moot Court Competition. He is a member of the American Academy of Arts and Sciences (elected 1992), the American Law Institute (since 1990), and the American Philosophical Society (elected 2010). He received an Honorary Doctorate from Copenhagen Business School. https://en.wikipedia.org/wiki/Cass_Sunstein
@Amy31129057 - QuestionIt
Behavioural and social sciences are critical for pandemic prevention, preparedness and response https://www.who.int/news-room/commentaries/detail/behavioural-and-social-sciences-are-critical-for-pandemic-prevention-preparedness-and-response
@Amy31129057 - QuestionIt
Interesting..... John Luman Smith..... Jack Before becoming an Assistant US Attorney, Mr. Smith served for five years as an Assistant District Attorney in the New York County District Attorney's Office where he was a member of the Office's Sex Crimes and Domestic Violence Units. He was also the vice president and head of litigation for one of the most corrupt organizations.... Hospital Corporation of America, now HCA in 2017.
@Amy31129057 - QuestionIt
Link~ https://www.scp-ks.org/en/us-prosecutor-jack-smith-appointed-specialist-prosecutor
@Amy31129057 - QuestionIt
All 👀 on deck..... Who is Susan Coller Monarez She is an American health scientist who is Principal Deputy Director of the Centers for Disease Control and Prevention (CDC) since 2025. She is currently also serving as the Acting Director of CDC. She was previously Deputy Director of the Advanced Research Projects Agency for Health. Monarez completed her Ph.D. at the University of Wisconsin–Madison She held roles in the Office of Science and Technology Policy and the U.S. National Security Council, where her work included initiatives to combat antimicrobial resistance, expand the use of wearable technology for health monitoring, and improve pandemic preparedness efforts. At the U.S. Department of Homeland Security, Monarez served as Deputy Assistant Secretary for Strategy and Data Analytics, overseeing research portfolios for the Homeland Security Advanced Research Projects Agency (HSARPA) and the Biomedical Advanced Research and Development Authority (BARDA).
@Amy31129057 - QuestionIt
Link- https://en.wikipedia.org/wiki/Susan_Monarez
@Amy31129057 - QuestionIt
I have some questions....... Nathan Wolfe, Mateabiota & Juul https://www.crunchbase.com/person/nathan-wolfe https://t.co/gLWdF1I2dp
@Amy31129057 - QuestionIt
@HousatonicLive - Housatonic.Live
We got Nathan Wolfe with Juul, Andrew Huff w/ Juul, Malone w/ Juul contracts, an FDA director on board of Juul ... And they say I am "controlled opposition" for showing how they use excess deaths from vaping to support the engineered-bioweapon-from-China-causing-COVID narrative. https://t.co/kinOiTTPiv
@Amy31129057 - QuestionIt
My oh my...... look at this older version of Wikipedia on GAIN OF FUNCTION..... They seem to have omitted some details from the current GAIN OF FUNCTION on Wikipedia today!
@Amy31129057 - QuestionIt
Link- https://web.archive.org/web/20210208070430/https://en.wikipedia.org/wiki/Gain_of_function_research
@Amy31129057 - QuestionIt
🤔Three Amino Acid Changes in Avian Coronavirus Spike Protein Allow Binding to Kidney Tissue (January 2020) Link in comments for those so inclined..... https://t.co/QCSp90VUen
@Amy31129057 - QuestionIt
@InvestigateJ6 - InvestigateJ6
BREAKING: NEW JAN 6 FOOTAGE RELEASED FROM THE PRODUCERS OF J6: A TRUE TIMELINE! FOOTAGE SHOWS THE FIRST MOMENTS OF J6 IN PRECISE DETAIL TIMESTAMPED MINUTE BY MINUTE: FROM THE TRUMP ELLIPSE SPEECH TO CROWDS ROAMING THE HALLS OF THE CAPITOL WITH ALL NEW MUST SEE 2025 J6 FOOTAGE!
@Amy31129057 - QuestionIt
@InvestigateJ6 Ray Epps was early in the video at 2:38, yet no mention of him until the 7:01 minute mark..... ??
@InvestigateJ6 - InvestigateJ6
@Amy31129057 Watch the full film. This is a short clip with additional new footage added.
@Amy31129057 - QuestionIt
The nine 👀's alliance is an extension of the Five Eyes. Apart from the five founding countries, it also includes Denmark, France, Norway, and the Netherlands. The 14👀's alliance was formed by the addition of 5 more countries to the Nine Eyes. Those were Belgium, Italy, Germany, Spain, and Sweden.
@Amy31129057 - QuestionIt
Kathleen Sebelius~ An American politician who served as the 21st United States Secretary of Health and Human Services from 2009 until 2014. Sits on the board of the Kaiser Family Foundation. Sebelius is a senior advisor to Out Leadership and the Aspen Institute, where she co-chairs the Aspen Health Strategy Group. Sebelius is a frequent keynote speaker for national and international organizations. You don't say @decentbackup
@Amy31129057 - QuestionIt
@Amy31129057 - QuestionIt
Sebelius envisions cell-based flu vaccine in 2011 (2010) @I_Am_JohnCullen @LmBubba Sep 29, 2010-Speaking at a Senate committee hearing today, US Health and Human Services (HHS) Secretary Kathleen Sebelius said a cell-based seasonal influenza vaccine from Novartis could be on the US market in time for the 2011-12 flu season. With the help of a $487 million HHS contract, Novartis Vaccines and Diagnostics recently built a facility in Holly Springs, N.C., to make cell-based flu vaccines and vaccine adjuvants. No cell-based flu vaccine has yet been licensed in the United States, though such vaccines have been approved in Europe. "Novartis opened its Holly Springs, North Carolina, facility in November 2009 in collaboration with the US Department of Health and Human Services (HHS)," the company said in a statement. "Novartis plans to file for cell-based vaccine technology in the US in the first half of 2011, but approval is contingent upon FDA [Food and Drug Administration] review, so we cannot confirm when cell-based vaccines would be on the market in the US." When the North Carolina plant was unveiled in 2009, Novartis officials said the earliest it could start making flu vaccine was 2011, with full commercial production expected in 2013. Sebelius made her comments at a hearing of the Senate Appropriations Committee's Labor-HHS Subcommittee on "Defending against public health threats." The session focused on HHS efforts to develop medical countermeasures against biological weapons. Sebelius also told the subcommittee that a recombinant flu vaccine from Connecticut-based Protein Sciences Corp. may also be licensed in time for the 2011-12 flu season. The company's application for approval of the vaccine is currently being reviewed by the FDA, according to the firm's Web site. The vaccine is made by using a baculovirus to grow the antigen in insect cells. Sebelius talked about the Novartis and Protein Sciences vaccines in response to questions from Sen. Tom Harkin, D-Iowa, chair of the subcommittee. He said the subcommittee has provided $15 billion for pandemic flu preparedness since 2006. That includes the money for the Novartis facility, he said, but "I hear it won't operate until 2013." In response, Sebelius noted that HHS has stockpiled a vaccine for H5N1 avian influenza, before discussing the Novartis and Protein Sciences vaccines. The HHS initiatives include, among others, improving the FDA's science capabilities, establishing advanced development and manufacturing centers for medical countermeasures, and speeding flu vaccine production by providing seed strains that grow better and improving sterility testing methods. Eric Rose, MD, co-chair of the Alliance for Biosecurity and head of a biotechnology company, defended the record of HHS's Biomedical Advanced Research and Development Authority (BARDA), the agency charged with developing biodefense tools. "The BARDA advanced development program is bearing fruit," said Rose, who is CEO of Siga Technologies, which is developing an antiviral for smallpox. "While many have criticized the slow pace, our experience is that the program is leading to important novel countermeasures less than 7 years" after it was launched. "There is a trickle, but the pipeline is beginning to flow." Pavia said the IDSA wants to see the countermeasures program get a consistent stream of funding. "We support at least $1.7 billion for BARDA for new countermeasures in 2011," he said. He told CIDRAP News this amount is well above what the Obama administration is proposing. https://www.cidrap.umn.edu/biosecurity-issues/sebelius-envisions-cell-based-flu-vaccine-2011
@Amy31129057 - QuestionIt
How many of you knew there is a BSL3 lab in Haiti???? Weill Cornell Medicine Center for Global Health-GHESKIO
@Amy31129057 - QuestionIt
Adding this here~ A BSL3 lab in Haiti....... what could possibly go wrong? Jean-William Pape, a professor of medicine at Cornell University’s Weill Medical College. Dr Jean William “Bill” Pape was born in Port-au-Prince, Haiti. He studied medicine in the United States and specialized in internal medicine and infectious diseases. Currently, he is Professor of Clinical Medicine at the Center of Global Health at Weill Cornell in the USA and Director of Centres at GHESKIO in Haiti. Additionally, he is involved with the Rodolphe Mérieux Laboratory in Port-au-Prince, Haiti, which is the only BSL3 laboratory operating in the country. This laboratory, part of the GABRIEL network created by the Mérieux Foundation in 2008, provides a platform for applied research and epidemiological surveillance in developing countries. This lab focuses on diagnosing diseases like bacterial pneumonia, tuberculosis, HIV/AIDS, sexually transmitted diseases, diarrheal diseases, and mycobacterial infections https://www.fondation-merieux.org/en/what-we-do/increasing-access-to-diagnostics/developing-infrastructure/rodolphe-merieux-laboratory-of-port-au-prince-haiti/
@Amy31129057 - QuestionIt
Here is the link..... https://www.eurosurveillance.org/images/dynamic/EE/V18N15/art20453.pdf
@Amy31129057 - QuestionIt
Have any prescribing doctors for Advair actually read the insert? Advair (which contains fluticasone, a corticosteroid, along with salmeterol, a long-acting beta-agonist), can increase the risk of pneumonia in patients. Understanding and managing the associated risks, including the increased susceptibility to pneumonia, is crucial! Here is the why....... Suppression of Immune Response: Local Immunosuppression: Corticosteroids work by reducing inflammation in the airways, which is beneficial for managing asthma or COPD symptoms. However, this anti-inflammatory effect also means they can suppress the immune response in the lungs. This suppression can make it harder for the body to fight off bacterial or viral infections, including those leading to pneumonia. Systemic Effects: Although inhaled steroids aim to minimize systemic effects, some of the drug can still be absorbed into the bloodstream, potentially affecting immune function throughout the body to a lesser extent. Alteration of Mucociliary Clearance: Steroids can alter the function of cilia, the tiny hair-like structures in the respiratory tract that help clear mucus and pathogens out of the lungs. Impaired ciliary function can lead to an accumulation of mucus, creating an environment conducive to bacterial growth and infection. Changes in Lung Flora: Long-term use of inhaled steroids might change the microbial flora in the lungs, potentially promoting the growth of opportunistic pathogens or altering the balance in a way that favors infection. Increased Susceptibility to Pathogens: The reduction in local immune defenses can make the lung tissue more susceptible to colonization by pathogens. Pneumonia-causing bacteria like Streptococcus pneumoniae or Haemophilus influenzae can take advantage of this weakened defense. Direct Effects on Lung Tissue: There's some evidence to suggest that steroids might affect the integrity of the lung epithelium, making it easier for pathogens to penetrate and cause infection. I wonder if pharmacists tell the patient when they are filling their prescription....... The more you know.🤓 Source: Advair Insert
@Amy31129057 - QuestionIt
I am asking for your help in sharing this! How many lives could have and should have been saved IF the proper treatment had been given early. The autopsies showed these patients had secondary bacterial pneumonia! Did doctors forget what killed so many during the Spanish Flu….. it was secondary bacterial pneumonia!!!
@Amy31129057 - QuestionIt
Did @MountSinaiNYC share their findings of both viral and bacterial pneumonia found in their autopsies of Covid patients….. ??? They pushed Remdesivir for treatment of pneumonia instead of the proper antibiotics….. https://t.co/mjhgbAokRR
@Amy31129057 - QuestionIt
🧵Now this one I did NOT see in the cards! Rick Bright is a member of the XPrize Foundation.... but there is WAY MORE! Take a peek- Some of their partners which include the Rand Corporation and ESRI (you know the ones that brought us the Covid map through Johns Hopkins) and others. https://xprize.org/about/people/rick-bright https://xprize.org/about/benefactors/foundationpartners https://xprize.org/About/benefactors/the-vision-circle https://xprize.org/about/benefactors/sponsors
Dr. Rick Bright is an international expert in vaccine, therapeutic and diagnostic development. Most recently, he served as a member of th
xprize.org
@Amy31129057 - QuestionIt
The Vision Circle - The Vision Circle is a membership of visionary philanthropists who underwrite the operations of XPRIZE at the highest level and provide thought leadership on the Foundation’s direction. Vision Circle members contribute a minimum of $500,000 per year. https://t.co/d8eYwywual
@Amy31129057 - QuestionIt
I saved the best for last..... the sponsors. Guess who is on the list!!! I HIGHLY encourage you to look at ALL the sponsors. This raises a TON of questions and concerns!! https://t.co/uvHrAF8mhl
@Amy31129057 - QuestionIt
You can't make this stuff up!!! You know those Covid testing swabs......by Yuan-Po Tu.... Take a look at who funded them!!!! @COVIDSelect @RandPaul @RepThomasMassie @I_Am_JohnCullen @LmBubba @ThomasWelch15 Polyester nasal swabs collected in a dry tube are a robust and inexpensive, minimal self-collection kit for SARS-CoV-2 testing Funding for this project was provided primarily by the Bill and Melinda Gates Foundation, through a direct award (BMGF COVID Grant Investment ID: INV-016831) to Quantigen Biosciences (LRP, LAK, CLA, DKS, JSE, and DR) and Audere (SDC). The funder provided support in the form of salaries for authors (LRP, LAK, CLA, DKS, MLW, SDC, JSE, and DR) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. Some reagents and consumables were provided free of charge to Quantigen by ThermoFisher. LRP, LAK, CLA, DKS, JSE, and DR are employed by Quantigen. YT is employed by The Everett Clinic-Part of Optum and MLW is employed by Sciest LLC. Swab specimens used to prepare “surrogate” SARS-CoV-2-positive samples for this study were provided by the Everett Clinic (Everett, WA; UnitedHealth Group protocol #2020–0002, approved by UHG Institutional Review Board). Oh and FYI Yuan-Po Tu is a research fellow for United Health Group!!! https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0245423
@Amy31129057 - QuestionIt
Good grief!! Supported by a grant to Drs. Cangelosi and Wood from the Bill and Melinda Gates Foundation. https://www.nejm.org/doi/full/10.1056/NEJMc2016321?query=TOC
@Amy31129057 - QuestionIt
On the flip side, meet Earl Bradley I learned about this guy when I was working in Delaware. What I didn't know is Beau Biden was overseeing this. H/T to @dezzie_rezzie Earl Brian Bradley is a former pediatrician from Philadelphia, Pennsylvania and convicted serial child rapist. He was indicted in 2010 on 471 charges of molesting, raping, and exploiting 103 child patients (102 girls and 1 boy). Some of the victims were as young as three months old. He was charged in April 2010 with an additional 58 offenses in relation to the abuse of 24 additional victims. He has been described by a number of reputable news outlets and commentators as "the worst pedophile in American history." Bradley was ultimately found guilty on all consolidated charges brought and was sentenced to 14 consecutive terms of life in prison without the possibility of parole plus 165 years in prison on June 26, 2011. His conviction was affirmed by the Delaware Supreme Court on September 6, 2012. In the wake of his arrest, it emerged that he had faced accusations of child abuse as early as 1995 in both Delaware and Pennsylvania. He opened his own practice in a small complex just a few blocks away, at Academy and Red Lion Roads in Morrell Park. He continued to work at Jefferson until a sudden move to Lewes, Delaware on the Delmarva Peninsula in 1995. The move was abrupt and poorly planned, with many patients complaining that they were not even notified that appointments had been cancelled. The medical offices, located near Lewes in unincorporated Sussex County, were ostentatiously decorated with carnival rides and other child-friendly decorations, such as a giant statue of Buzz Lightyear from Disney's Toy Story and a small movie theatre showing Disney movies. He owned several vehicles which were painted yellow and black with eyes and a tail to resemble bumblebees. The oddities extended to his home, where he prominently displayed a full suit of medieval armor on his porch. The first known allegations of inappropriate conduct by Bradley came in 1994 when Thomas Jefferson University Hospital investigated a patient's complaint of sexual misconduct. There was a second allegation in 1995. The hospital could not verify the claim, and records remain sealed. Allegations were made again in 2005. Police records show that a nurse reported that he videotaped kids playing and other doctors reported complaints about long and unnecessary vaginal exams. When police in Milford, Delaware sought a warrant to arrest him for inappropriately touching a child patient, the Attorney General's office concluded at the time that there was insufficient evidence to warrant prosecution. On December 16, 2009, following a year-long investigation and complaints of inappropriate touching by a two-year-old patient, Bradley was arrested and charged with nine counts, including a felony charge for a fourth degree rape of a two-year-old patient. Soon after, relying on more than 13 hours of videotaped rapes and molestations discovered by police in Bradley's home and office, additional warrants were issued. These included felony warrants for several counts of child exploitation and first-degree rape. Bradley had videotaped sexual assaults during which his victims "appeared to lose consciousness" from Bradley choking them by forcing oral sex on his child victims. The videos also show children in diapers screaming as they attempted to escape from Bradley before he raped them in an outbuilding on the property. Delaware Attorney General Beau Biden, son of then Vice President Joe Biden, announced in a January 2010 speech that he would not seek election to his father's former seat in the United States Senate because he felt it was more important to fully pursue Bradley's prosecution. Bradley's case was moved to New Castle County from Sussex County because of concerns about getting an impartial jury in Sussex County, as many families of his 127 alleged victims lived there. However, Bradley then waived his right to a jury trial, opting instead for a bench trial. The case was then moved back to Sussex County. After hearing evidence on June 7, 2011, Judge William C. Carpenter, the presiding Judge in Bradley's bench trial, stated he would issue his verdict at a later date. The office complex housing his former practice was demolished on October 10, 2011. The former site of the office building is now home to Herbalife store Turtley Awesome Nutrition. Earlier, state police confiscated the contents of Bradley's storage locker in Rehoboth Beach and destroyed them; the items were to be auctioned off to satisfy unpaid rent, but Biden intervened on behalf of the victims to buy them for a symbolic $1 so as not to take the chance of them ever being used again. Bradley was held in the Special Housing Unit (SHU) of the James T. Vaughn Correctional Center in New Castle County until 2016, when Delaware authorities announced they would move him to an out-of-state prison because many of his victims and/or state residents otherwise affected by his actions either worked in or were incarcerated in Delaware prisons. Connecticut authorities revealed that Bradley was moved to the Cheshire Correctional Institution in Cheshire, Connecticut. https://en.wikipedia.org/wiki/Earl_Bradley
@Amy31129057 - QuestionIt
Unreal~ Who is Robert H. Richards IV He is a convicted child rapist and great-grandson of chemical magnate Irénée du Pont and heir to the du Pont family fortune. In 2009, Richards entered a guilty plea and was convicted of raping his 3-year-old daughter, after the girl reported the abuse to her grandmother. Instead of serving out his eight-year prison sentence, the sentencing order signed by Delaware Superior Court Judge Jan R. Jurden reportedly considered that the "defendant will not fare well" in prison and the eight-year sentence was suspended. In 2010, allegations were made that Richards had also molested his son beginning in December 2005 and continuing for two years. Police and prosecutors investigated but did not find sufficient evidence to pursue charges. Delaware Attorney General Beau Biden later defended the sentencing of Richards to probation, saying there was a strong chance of the prosecution losing at trial making a plea bargain necessary, noting the weakness of the evidence. Although Richards was ordered by Jurden to go through in-patient treatment at a Massachusetts facility, he has failed to do so. Later there was a lawsuit also claims that the polygraph tests Richards took in April 2010 during his probation supported allegations that he had molested his son. Beau Biden was criticized for his handling of the prosecution of Robert H. Richards IV, an heir of the powerful Delaware-based Du Pont family accused of sexually assaulting his young daughter. In 2008, Biden's office charged Richards with two counts of second-degree rape, charges punishable by a minimum of 20 years in prison, but later that year, his office entered a plea bargain with Richards in which Richards pleaded guilty to one count of fourth-degree rape and was sentenced by Judge Jan Jurden to eight years' probation. https://en.wikipedia.org/wiki/Trial_and_sentencing_of_Robert_H._Richards_IV https://en.wikipedia.org/wiki/Beau_Biden
@Amy31129057 - QuestionIt
Let me get this right- Timothy Geithner a former yuppie of Obama, Biden and Hillary Clinton goes to become chairman of Warburg Pincus who is responsible for "incubating CrowdStrike" that is responsible for cybersecurity of our nation's computer infrastructure and election security. 🤔 You have got to be kidding me!!!! @DecentBackup
@Amy31129057 - QuestionIt
Who is Timothy Franz Geithner- During the time of the Operation Aurora, Timothy Franz Geithner was a central banker who served as the 75th United States Secretary of the Treasury under President Barack Obama from 2009 to 2013. During the 2008 presidential campaign, Geithner was rumored to be a possible choice for Treasury Secretary for both John McCain and Barack Obama. On November 24, 2008, President-elect Barack Obama announced his intention to nominate Geithner to be Treasury Secretary. Geithner was sworn in as Treasury Secretary by Vice President Joe Biden and witnessed by President Barack Obama He was the President of the Federal Reserve Bank of New York from 2003 to 2009, following service in the Clinton administration. Since March 2014, he has served as president and chairman of Warburg Pincus, a private equity firm headquartered in New York City. As President of the New York Fed and Secretary of the Treasury, Geithner had a key role in government efforts to recover from the financial crisis of 2007–08 and the Great Recession. At the New York Fed, Geithner helped manage crises involving Bear Stearns, Lehman Brothers, and the American International Group; as Treasury Secretary, he oversaw allocation of $350 billion under the Troubled Asset Relief Program, enacted during the previous administration in response to the subprime mortgage crisis. Geithner also managed the administration's efforts to restructure regulation of the nation's financial system, attempts to spur recovery of the mortgage market and the automobile industry, demands for protectionism, tax reform, and negotiations with foreign governments on global finance issues. Geithner was born in Manhattan, New York, to Peter Franz Geithner and Deborah Moore. His father, a German American, was the director of the Ford Foundation's Asia program in New York during the 1990s, after working for the United States Agency for International Development in Zambia and Zimbabwe. During the early 1980s, Geithner's father oversaw the Ford Foundation's microfinance programs in Indonesia being developed by Ann Dunham Soetoro, Barack Obama's mother, and they met at least once in Jakarta. Geithner's mother, a Mayflower descendant, belongs to a New England family. Her father, Charles Frederick Moore, Jr., served as vice-president of public relations for the Ford Motor Company from 1952 to 1964, and advised President Dwight D. Eisenhower, as well as Nelson Rockefeller and George W. Romney, on their respective presidential campaigns. His uncle, Jonathan Moore, served in the departments of Defense, Justice and State, as well as in the United Nations. Geithner spent most of his childhood living abroad, including in Zimbabwe; Zambia; India; and Thailand, where he completed high school at the International School Bangkok. He studied Mandarin at Peking University in 1981, and at Beijing Normal University in 1982. Like his father, paternal grandfather and uncle; Geithner attended Dartmouth College, graduating in 1983, with an A.B. in Government and Asian studies, then earned a M.A. in international economics and East Asian studies from Johns Hopkins University's School of Advanced International Studies, in 1985. Geithner worked for Kissinger Associates in Washington, D.C., from 1985 to 1988, when he joined the International Affairs division of the U.S. Treasury Department. He served as an attaché at the Embassy of the United States in Tokyo, then as deputy assistant secretary for international monetary and financial policy (1995–1996), senior deputy assistant secretary for international affairs (1996–1997), and assistant secretary for international affairs (1997–1998). He was Under Secretary of the Treasury for International Affairs (1998–2001) under Secretaries Robert Rubin and Lawrence Summers, who are widely considered to have been his mentors. He was director of the Policy Development and Review Department at the International Monetary Fund from 2001 to 2003. Geithner left the Obama administration on January 25, 2013, and joined the Council on Foreign Relations as a Distinguished Fellow. In March 2014, he became the president and managing director of Warburg Pincus, a private equity firm. In February 2016, it was announced that JPMorgan Chase would provide a line of credit to help Warburg Pincus executives invest in a new multibillion-dollar fund at the firm. In July 2023, he became chairman of Warburg Pincus. Read more here- 👇 https://en.wikipedia.org/wiki/Timothy_Geithner
@Amy31129057 - QuestionIt
Might as well add this~ CrowdStrike and Google Cloud Announce Strategic Partnership to Transform AI-Native Cybersecurity https://www.crowdstrike.com/press-releases/crowdstrike-and-google-cloud-partnership-transforms-ai-native-cybersecurity/
@Amy31129057 - QuestionIt
Pay Attention~ Warburg Pincus LLC & CrowdStrike go hand in hand! As of 2020, Crowdstrike has over a dozen products, all built on this common architecture, and analyzes more than 100b+ events per day from over 11m sensors deployed. Warburg Pincus incubated Crowdstrike and helped form the company’s initial business plan as its seed investor. The firm provided strategic and tactical advice and committed to an “line of equity” for future financings. As Crowdstrike scaled, Warburg Pincus helped build out the company’s core team by assisting with the hiring of key executives across functional areas and the onboarding of independent board members. Warburg Pincus was Crowdstrike’s largest shareholder from inception through its IPO on the Nasdaq in June 2019, supporting growth from $0 to $686m of annual recurring revenue by the time the firm exited its investment in 2020. https://warburgpincus.com/case-studies/crowdstrike-2/ https://warburgpincus.com/case-studies/crowdstrike/ https://crowdstrike.com/blog/google-capital-bets-big-on-crowdstrike/ https://seekingalpha.com/article/4316486-exploring-crowdstrikes-competitive-advantage
@Amy31129057 - QuestionIt
Who is Timothy Franz Geithner- During the time of the Operation Aurora, Timothy Franz Geithner was a central banker who served as the 75th United States Secretary of the Treasury under President Barack Obama from 2009 to 2013. During the 2008 presidential campaign, Geithner was rumored to be a possible choice for Treasury Secretary for both John McCain and Barack Obama. On November 24, 2008, President-elect Barack Obama announced his intention to nominate Geithner to be Treasury Secretary. Geithner was sworn in as Treasury Secretary by Vice President Joe Biden and witnessed by President Barack Obama He was the President of the Federal Reserve Bank of New York from 2003 to 2009, following service in the Clinton administration. Since March 2014, he has served as president and chairman of Warburg Pincus, a private equity firm headquartered in New York City. As President of the New York Fed and Secretary of the Treasury, Geithner had a key role in government efforts to recover from the financial crisis of 2007–08 and the Great Recession. At the New York Fed, Geithner helped manage crises involving Bear Stearns, Lehman Brothers, and the American International Group; as Treasury Secretary, he oversaw allocation of $350 billion under the Troubled Asset Relief Program, enacted during the previous administration in response to the subprime mortgage crisis. Geithner also managed the administration's efforts to restructure regulation of the nation's financial system, attempts to spur recovery of the mortgage market and the automobile industry, demands for protectionism, tax reform, and negotiations with foreign governments on global finance issues. Geithner was born in Manhattan, New York, to Peter Franz Geithner and Deborah Moore. His father, a German American, was the director of the Ford Foundation's Asia program in New York during the 1990s, after working for the United States Agency for International Development in Zambia and Zimbabwe. During the early 1980s, Geithner's father oversaw the Ford Foundation's microfinance programs in Indonesia being developed by Ann Dunham Soetoro, Barack Obama's mother, and they met at least once in Jakarta. Geithner's mother, a Mayflower descendant, belongs to a New England family. Her father, Charles Frederick Moore, Jr., served as vice-president of public relations for the Ford Motor Company from 1952 to 1964, and advised President Dwight D. Eisenhower, as well as Nelson Rockefeller and George W. Romney, on their respective presidential campaigns. His uncle, Jonathan Moore, served in the departments of Defense, Justice and State, as well as in the United Nations. Geithner spent most of his childhood living abroad, including in Zimbabwe; Zambia; India; and Thailand, where he completed high school at the International School Bangkok. He studied Mandarin at Peking University in 1981, and at Beijing Normal University in 1982. Like his father, paternal grandfather and uncle; Geithner attended Dartmouth College, graduating in 1983, with an A.B. in Government and Asian studies, then earned a M.A. in international economics and East Asian studies from Johns Hopkins University's School of Advanced International Studies, in 1985. Geithner worked for Kissinger Associates in Washington, D.C., from 1985 to 1988, when he joined the International Affairs division of the U.S. Treasury Department. He served as an attaché at the Embassy of the United States in Tokyo, then as deputy assistant secretary for international monetary and financial policy (1995–1996), senior deputy assistant secretary for international affairs (1996–1997), and assistant secretary for international affairs (1997–1998). He was Under Secretary of the Treasury for International Affairs (1998–2001) under Secretaries Robert Rubin and Lawrence Summers, who are widely considered to have been his mentors. He was director of the Policy Development and Review Department at the International Monetary Fund from 2001 to 2003. Geithner left the Obama administration on January 25, 2013, and joined the Council on Foreign Relations as a Distinguished Fellow. In March 2014, he became the president and managing director of Warburg Pincus, a private equity firm. In February 2016, it was announced that JPMorgan Chase would provide a line of credit to help Warburg Pincus executives invest in a new multibillion-dollar fund at the firm. In July 2023, he became chairman of Warburg Pincus. Read more here- 👇 https://en.wikipedia.org/wiki/Timothy_Geithner
@Amy31129057 - QuestionIt
Adding the Falcon Platform- https://www.crowdstrike.com/platform/
@Amy31129057 - QuestionIt
Give me a pathogen..... Metabiota & Wellcome Trust~ The genesis and source of the H7N9 influenza viruses causing human infections in China (2013). Metabiota's involvement was supported by the U.S. Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project, under the terms of Cooperative Agreement Number GHN-A-OO-09-00010-00. The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007–2013] under Grant Agreement no. 278433-PREDEMICS, ERC Grant agreement no. 260864 and the Wellcome Trust (grant 092807) to A.R. and S.J.L. We thank our colleagues from the Joint Influenza Research Centre (SUMC/HKU) and the State Key Laboratory of Emerging Infectious Diseases for their technical assistance. This study was supported by the National Institutes of Health (National Institute of Allergy and Infectious Diseases contract HSN266200700005C), Li Ka Shing Foundation, the Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR (grant AoE/M-12/06), Shenzhen Peacock Plan High-End Talents Program (KQTD201203), the University Development Fund (HKU) and the Innovation and Technology Commission of the Hong Kong Government. T.T.-Y.L. was supported in part by a Newton International Fellowship of the Royal Society. https://ncbi.nlm.nih.gov/pmc/articles/PMC3801098/
@Amy31129057 - QuestionIt
@CanariesBlue I know you did a lot of work on Metabiota......
@Amy31129057 - QuestionIt
🚨🚨PAY ATTENTION
Recap 2009
Young children need 2 doses of H1N1 vaccine-
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said young children will likely need to have their doses 21 days apart.
Separately, Sanofi said it had won a U.S. government order for 27.3 million more doses of its vaccine and AstraZeneca's
@Amy31129057 - QuestionIt
Pay attention @RandPaul @RepThomasMassie @realDonaldTrump Submitted (16-NOV-2019) Laboratory of Surveillance for Avian Diseases, China Animal Health and Epidemiology Center, No. 369 Nanjing Road, Qingdao, Shandong 266032, China Antigenic Variant of Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2019
@Amy31129057 - QuestionIt
H7N9 in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats. Earlier mass vaccination of poultry with H7-Re1 successfully induced a sharp decline in H7N9 infection prevalence among poultry and humans. However, as of 2019, H7N9 variants have surfaced, posing a considerable economic and public health threat and highlighting the urgent need for new antigen-matched vaccines and more productive measures to eliminate highly pathogenic H7N9 viruses. According to the deduced amino acid sequence of HA, all strains contained multiple basic amino acids (PKRKRTAR/GLF) at the cleavage site, suggestive of high pathogenicity. We determined that the amino acid residues at the receptor-binding site of HA proteins are A138, V186, P221, and Q226 (H3 numbering), which suggests that these viruses could bind receptors in birds and humans https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986829/
@Amy31129057 - QuestionIt
It is time to wake up~ This goes back to 2013 @RandPaul @RepThomasMassie NIH, DARPA, USAMIIRD and many more. @I_Am_JohnCullen @LmBubba H7N9........Extremely rapid H7N9 vaccine design by Epivax from Annie De Groot See the entire 44 slides here~ https://epivax.com/blog/epivax-h7n9-shanghai-2013-fastvax-update
@Amy31129057 - QuestionIt
Don't forget to add Bill Gates into the mix! https://x.com/Amy31129057/status/1742983077704679839?s=20
@Amy31129057 - QuestionIt
For fucks sake!!! Pardon my mouth...... see the attached post! AbCellera today announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. @RandPaul @RepThomasMassie Press Release: EpiVax Announces Licensing of Immunogenicity Screening Toolkit, ISPRI, to AbCellera by Annie De Groot | Jun 8, 2020 AbCellera is a privately held biotech with a drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, big data, machine learning, bioinformatics, and genomics, identifies new first-in-class drugs and reduces the time it takes to bring treatments to clinic. AbCellera’s partners include leading biotechnology companies, global health organizations, and six of the top 10 biopharmaceutical companies. https://epivax.com/news/epivax-announces-licensing-of-immunogenicity-screening-toolkit-ispri-to-abcellera
@Amy31129057 - QuestionIt
Who is Eric Feigl-Ding~ and why did he delete his earliest tweets on the pandemic? I wonder if I should let him know about a spelling error on his website? 😏 An American public health scientist who is currently an epidemiologist and Chief of COVID Task Force at the New England Complex Systems Institute. He was formerly a faculty member and researcher at Harvard Medical School and Harvard T.H. Chan School of Public Health. He is also the Chief Health Economist for Microclinic International, and co-founder of the World Health Network. His research and advocacy have primarily focused on obesity, nutrition, cancer prevention, and biosecurity. In January 2020, Feigl-Ding sounded an early alarm about COVID-19 and called for preparedness. His call for pandemic alarm went viral on Twitter and was amplified by media outlets. During the COVID-19 pandemic, Feigl-Ding's Twitter posts on the matter have been popular. His tweets on the pandemic have been criticized by other scientists as alarmist, misleading, and inaccurate. In 2004, he completed his undergraduate studies at Johns Hopkins University with Honors in Public Health. He completed his dual Doctor of Science doctoral program in epidemiology and doctoral program in nutrition from Harvard University in 2007. He attended Boston University School of Medicine, but did not complete the M.D. program. Feigl-Ding was awarded a Paul and Daisy Soros Fellowship for his graduate studies. He was one of over 3,000 researchers who participated in the Global Burden of Disease Study, funded by the Bill & Melinda Gates Foundation. He compared the virus pandemic potential to the 1918 influenza pandemic which has an estimated R0 of 1.8 and which killed ~50 million people out of 2 billion, and called for WHO and CDC to preemptively declare public health emergency and monitor aggressively the situation. Feigl-Ding has said he is not sub-specialized in infectious diseases and claims to have never misrepresented himself as an infectious disease epidemiologist. Feigl-Ding's rapid rise to prominence as a TV and media commentator and expert during the COVID-19 pandemic, despite his lack of academic activity in infectious diseases, has led to much criticism and controversy. Feigl-Ding was a candidate in the 2018 Democratic primary for Pennsylvania's 10th congressional district. On February 27, 2018, Feigl-Ding announced his candidacy in the Democratic primary for Pennsylvania's 10th congressional district. He campaigned on a progressive platform advocating for science, universal healthcare, and public health. During the run up to the election, Feigl-Ding did not take corporate PAC money. He received 18% of the vote to George Scott's 36% in a 4-person primary. He was invited to join the Global Shapers program of the World Economic Forum,[5] and joined in February 2013. Previously, during the 2014 Ebola pandemic, he led a team to co-develop one of the first mobile contact-tracing applications for infectious disease outbreaks. The project was shelved after lack of interest in pandemic preparedness technology. His early contact-tracing app’s contributions lived on to inform the later designs of contact tracing apps developed during the COVID-19 outbreak. Altogether, his competitively awarded projects as PI/Director have received over $10 million in funding. A World Economic Forum Global Shaper, he has chaired committees for the Health Directorate of the European Commission, advised the World Health Organization, Denmark Ministry of Health, and served as a member of the Global Burden of Disease Project. He also advised and successfully convinced the C-suite leaders of a major Fortune 100 food/beverage company to adopt the WHO health recommendations for added sugars. He has also advised many governors, state legislators, members of Congress, and other world leaders. https://whn.global/expert/eric-feigl-ding/ https://en.wikipedia.org/wiki/Eric_Feigl-Ding
@Amy31129057 - QuestionIt
Good grief! I just realized who Rod Jay Rosenstein is. Add his corruption to his sister Nancy that oversaw the CDC at the time the pandemic was announced. 🤦♀️ Who is Rod Rosenstein~ An American attorney who served as the 37th United States deputy attorney general from April 2017 until May 2019. Prior to his appointment, he served as a United States attorney for the District of Maryland. In May 2018, Rosenstein reportedly told the five U.S. Attorneys in districts along the border with Mexico that, where refugees were concerned, they should not "be categorically declining immigration prosecutions of adults in family units because of the age of a child." Following the recusal of Attorney General Jeff Sessions and Comey's dismissal, Rosenstein appointed Robert Mueller as special counsel to investigate the myriad links between Trump associates and Russian officials and spies and related matters. 🙄 President George W. Bush nominated Rosenstein to serve as the United States Attorney for the District of Maryland on May 23, 2005. He took office on July 12, 2005, after the U.S. Senate unanimously confirmed his nomination. He was the only U.S. Attorney retained by President Barack Obama. It goes on and on you can read it at the link below. I would like to point out one last point- Rosenstein is married to Lisa Barsoomian, an Armenian American lawyer who worked for the National Institutes of Health until 2011. As a government attorney, Barsoomian represented the United States in various matters, including Freedom of Information Act (FOIA) cases, and the FBI's "Carnivore" surveillance system, which monitors and captures e-mail. Rosenstein resides in Bethesda, Maryland https://en.wikipedia.org/wiki/Rod_Rosenstein
@Amy31129057 - QuestionIt
I have questions for you NANCY. It states On January 21, 2020, you announced that the CDC had finalized its own COVID-19 test- yet the CDC made their own PCR test AFTER the first patient in Washington State was found, which they didn't take a sample until January 25th. Explain that one please! Who is ~ Nancy Messonnier @I_Am_JohnCullen @LmBubba @RandPaul @RepThomasMassie @DecentFiJC An American physician who served as the director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention from 2016 to 2021. She worked on the CDC's response to the COVID-19 pandemic in the United States. She grew up in Lower Moreland Township, Pennsylvania, with her brother Rod Rosenstein. Messonnier began her career in public health in 1995 as an epidemic intelligence service officer in the National Center for Infectious Diseases, a program of the Centers for Disease Control and Prevention (CDC). During her tenure at the CDC, she led the Meningitis and Vaccine Preventable Diseases Branch in NCIRD's Division of Bacterial Diseases from 2007 to 2012. She also served as the deputy director of NCIRD from 2014 to 2016 before becoming director of the center on April 4, 2016. During the course of her career, Messonnier notably worked on the 2001 anthrax attacks response, serving as co-leader of the anthrax management team and vaccine working group. Starting January 2020, Messonnier helped lead the CDC efforts to address and combat the emerging threat of COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2). When 195 Americans were evacuated out of Wuhan because of the virus, the CDC moved to quarantine all of them, with Messonnier noting: "While we realize this is an unprecedented action, this is an unprecedented threat. In a February 25 press briefing at the White House, Messonnier warned of the impending community spread of the virus in the United States, stating: "Disruption to everyday life might be severe." While Messonnier no longer appeared in White House briefings, she continued giving regular CDC briefings, which were broadcast to the public, until April 2020, and she made public appearances in All Things Considered on NPR. On March 9, 2020 she cautioned those who were at high risk of severe illness, including the elderly and people with pre-existing conditions, to take cautionary measures such as stocking up on groceries and medications, and preparing to shelter in place for the foreseeable future. She also addressed concerns around the CDC and FDA's failure to get working COVID-19 testing kits into the hands of public health officials in a timely manner to enable better containment of the disease and mitigation of its spread. On January 21, 2020, she announced that the CDC had finalized its own COVID-19 test. On February 5, the CDC began distributing diagnostic tests to public-health laboratories; however, several of those tests had contaminated reagents, rendering them useless, and leading to a major gap in fighting the outbreak. The situation was exacerbated by FDA-imposed regulations on testing, making it difficult for independent development of COVID-19 tests to fill the CDC's distribution gap. On May 7, 2021 she told colleagues she was resigning from the CDC effective May 14, saying "now is the best time for me to transition to a new phase of my career." She said she would become executive director for pandemic and public health systems at the Skoll Foundation, based in Palo Alto, California. On June 22, 2022 the UNC Gillings School of Global Public Health at the University of North Carolina at Chapel Hill announced that Messonnier had been appointed to serve as the school’s dean following the departure of Barbara Rimer, effective September 1, 2022 https://en.wikipedia.org/wiki/Nancy_Messonnier https://en.wikipedia.org/wiki/Rod_Rosenstein
@Amy31129057 - QuestionIt
Were they wrong about Molnupiravir? Molnupiravir was originally developed to treat influenza at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns when used in Covid patients. Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It was used to treat COVID-19 in those infected by SARS-CoV-2. It is taken by mouth. For several years, Emory scientists had been working on EIDD-2801, a drug candidate with potential as a treatment for several highly infectious and worrisome viral diseases, including influenza and Venezuelan Equine Encephalitis virus, some of which are biodefense threats. When the pandemic began, the team quickly turned its attention to developing EIDD-2801 as a treatment for COVID-19. DRIVE licensed EIDD-2801, now known as molnupiravir, to Ridgeback Biotherapeutics in 2020, which conducted the first human clinical trials and then partnered with Merck. In October 2021 the UK government announced the procurement of 480 000 courses of molnupiravir (as well as 250 000 courses of the Pfizer antiviral Paxlovid (nirmatrelvir)). Guess who they went with.... PAXLOVID. 😏 https://en.wikipedia.org/wiki/Molnupiravir https://drugdiscovery.emory.edu/molnupiravir/index.html https://bmj.com/content/377/bmj.o926
@Amy31129057 - QuestionIt
Good Grief, Pay Attention~ Anti-viral drug backfires: COVID drug linked to viral mutations that spread. Merck's small-molecule molnupiravir linked to mutated viruses that spread in people. (September 26, 2023) According to a new peer-reviewed study in the journal Nature, the anti-viral drug dubbed molnupiravir is linked to specific SARS-CoV-2 mutation signatures that happened to spring up in 2022 when the drug was introduced. The study's authors—led by researchers at the Francis Crick Institute in London and the University of Cambridge—scanned through more than 15 million SARS-CoV-2 genome sequences found in global databases. They picked out unique mutation signatures that closely linked to signatures seen in viruses from patients known to have been treated with molnupiravir. These suspected molnupiravir-linked mutation signatures also matched those seen in viruses examined in a clinical trial of molnupiravir. https://arstechnica.com/health/2023/09/covid-anti-viral-drug-is-actively-helping-sars-cov-2-mutate-and-evolve/
@Amy31129057 - QuestionIt
Question IT! https://x.com/Amy31129057/status/1735456355300045068?s=20
@Amy31129057 - QuestionIt
Please look into this more @RandPaul @RepThomasMassie @SenRonJohnson @Leeshotfury1966 @I_Am_JohnCullen @LmBubba Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels (March 17, 2021) Ridgeback Biotherapeutics~ Ridgeback Biotherapeutics is a Miami-based biotechnology company, primarily known for its involvement in developing a successful COVID-19 medication. Ridgeback is privately owned by hedge fund manager and physician, Wayne Holman (formerly of S.A.C. Capital Advisors) and his wife Wendy Holman. Wendy is the CEO at the company, which refers to itself as a majority woman owned business. In early 2020, Ridgeback purchased an exclusive license for the commercial development of Molnupiravir from Emory University, where the drug was initially developed with $16 million in grants from Federal agencies including the National Institutes of Health. The terms of the deal were undisclosed. Molnupiravir was initially researched as a treatment for influenza, but may have broad spectrum activity against other viruses. Ridgeback was mentioned in a whistleblower complaint from Rick Bright, former director of the Biomedical Advanced Research and Development Authority (BARDA). The complaint alleged that Ridgeback lobbied the government for millions in funding to help develop Molnupiravir. Merck & Co. partnered with Ridgeback to perform clinical trials with Molnupiravir in humans to treat COVID-19. An antiviral drug initially discovered by Emory’s non-profit drug development company DRIVE appears safe and reduces SARS-CoV-2 to undetectable levels in COVID-19 patients after five days of administration, according to data from a Phase II clinical trial in the United States. Molnupiravir, previously known as EIDD-2801, can be provided as a pill in an outpatient setting, which could be a step up in ease of distribution and convenience. Although remdesivir and antiviral monoclonal antibodies have received Emergency Use Authorizations from the FDA, they must be given intravenously or by injection. In addition, drugs like molnupiravir could flexibly tackle SARS-CoV-2 variants, which have emerged as a concern in recent months. "There's still an urgent need for an antiviral drug against SARS-CoV-2 that can be easily produced, transported, stored, and administered," says George Painter, PhD, CEO of DRIVE (Drug Innovation Ventures at Emory) and director of the Emory Institute for Drug Development. When the COVID-19 pandemic began, DRIVE quickly repurposed a broad-spectrum antiviral drug it had been developing against influenza and equine encephalitis. Molnupiravir is being developed further by Merck and its partner Ridgeback Biotherapeutics, a closely held biotechnology company, which licensed the drug from DRIVE last year. All funds for the post-licensing development of EIDD-2801/molnupiravir have been provided by Ridgeback and Merck. In the most recent clinical study, molnupiravir eliminated infectious coronavirus from nose swabs within five days in all of the people taking it. For comparison, a quarter of people receiving placebo still had detectable virus in their nose swabs at day five. Emory physicians were not involved in the clinical trial, which recruited 202 adults with COVID-19 symptoms at outpatient clinics in the United States. The data were presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI). While molnupiravir is proven to interfere with coronavirus replication in infected patients, more data is required to determine whether it can prevent severe illness. Merck and Ridgeback say that more results from the U.S. clinical trial will be shared when they become available, and additional Phase 2 and 2/3 clinical studies are underway. Molnupiravir has also been tested for safety in a clinical trial in the United Kingdom. Molnupiravir works by forcing the viral enzyme that copies SARS-CoV-2’s genetic material to make so many mistakes that the virus can’t replicate. Still, Merck’s comprehensive testing indicates that high doses of the drug are not mutagenic in animals. Emory scientists, in collaboration with top coronavirus experts at other universities, have previously shown that EIDD-2801 is highly effective at interfering with coronavirus replication and transmission in animal models and also in mice implanted with human lung tissue. EIDD-2801 has broad spectrum activity against a number of diseases of public health concern, including influenza, SARS-CoV-1, MERS, chikungunya, Ebola and equine encephalitis. The drug was initially developed with the support of the National Institute of Allergy and Infectious Diseases, the Defense Threat Reduction Agency, and the Georgia Research Alliance's Venture Development program. https://news.emory.edu/stories/2021/03/coronavirus_DRIVE_molnupiravir/index.html https://en.wikipedia.org/wiki/Ridgeback_Biotherapeutics https://www.science.org/content/article/emails-offer-look-whistleblower-charges-cronyism-behind-potential-covid-19-drug https://en.wikipedia.org/wiki/Molnupiravir
@Amy31129057 - QuestionIt
The Origins of Pandemic Influenza — Lessons from the 1918 Virus (November 24, 2005) @I_Am_JohnCullen @LmBubba The characterization of the recovered 1918 virus in tissue culture and mice reveals at least two unique qualities. This virus is able to replicate and form plaques on tissue-culture monolayers in the absence of the protease trypsin. Normally, a protease such as trypsin is required to activate the hemagglutinin in order to initiate the infection of tissue culture, but the 1918 virus can activate its own hemagglutinin through the action of neuraminidase, either directly or indirectly (possibly by neuraminidase's binding of a host protease). The exact mechanism by which the neuraminidase takes on the protease activity has not been determined. The vigorous release of cytokines in mice infected with the 1918 influenza virus is associated with rapid onset of pulmonary disease and death. https://www.nejm.org/doi/full/10.1056/NEJMp058281
@Amy31129057 - QuestionIt
And there you have it~ Who is Dr. Carlo de Notaristefani~ OPERATION WARP SPEED @RandPaul @RepThomasMassie @I_Am_JohnCullen @LmBubba @Kevin_McKernan PANDEMIC BEGINNING At the end of 2019, I had just retired from my position as Executive Vice President of Operations for a large global pharmaceutical manufacturer (TEVA), with plans for easing into advisory or board roles and enjoying more time sailing and biking. However, the evolution of the pandemic made my retirement plans less viable. My first contact with the US government project to fight the pandemic occurred one morning in April 2020, while I was biking empty roads in New Jersey, which was a rare situation I had not experienced since the great financial crisis of 2008. I received two calls, the first from Bob Kadlec, Assistant Director at HHS for Preparedness and Response, and the second from Alex Azar, Secretary of HHS. They described how the US government had determined that the best way to fight the pandemic was to mobilize the public resources of the government and the scientific innovation and the entrepreneurial spirit of the industry in order to pull out all stops and accelerate the development of safe and effective vaccines and any other treatment we could develop. They compared this effort to the Manhattan Project, which aimed to end World War II, and they asked about my availability to participate, advise, and coordinate all aspects of the project related to the manufacturing. This proposal was a dream come true: not only had I been given the opportunity to do something for the industry and my country, which have both given me so much, but I also had a real shot at escaping the boredom of lockdown and retirement. Being in the fortunate position of having control of my time, I gave my full commitment and that’s how my experience with Operation Warp Speed started. OPERATION WARP SPEED Over the following few weeks, the structure of this project was better defined and an overall leader was appointed. Moncef Slaoui, a former GSK R&D executive with significant vaccine development experience and a successful industry track record, was named Chief Scientific Advisor and overall program lead. The lead of all US government resources was General Gustave Perna, a four-star general who had been leading US Army Logistics, an enormous organization, and who had deep supply chain knowledge. Slaoui and Perna built an incredible partnership throughout the time they worked together leading the operation, and shaped the culture and the team spirit that ultimately made everything possible. This was a culture of fact-based and data-driven decisions, empowerment with accountability, and personal commitment, starting from the leadership. Perna used to say that “as long as something is not illegal, immoral or unethical, we will find a way to make it happen.” And he certainly did. Key decisions were escalated to a board chaired by the Secretary of HHS and the Secretary of Defense with participation from the White House, the National Institutes for Health (NIH), the FDA, the Centers for Disease Control and Prevention (CDC), the Assistant Secretary for Preparedness and Response (ASPR), and Operation Warp Speed leadership. This board met weekly to be updated on progress, endorse recommendations for critical decisions, and provide support with resources as needed. A lot of work was happening behind the scenes, of course, to gain the political endorsement and the funding for the operation, and a special credit goes to Azar and his Deputy Chief of Staff Paul Mango for successfully bringing it forward and shielding the operation from external noise. THE DEVELOPMENT The global effort to develop a vaccine for COVID-19 started on 10 January 2020, when a Chinese virology team posted the genetic sequence of the virus on a global public health site. Several pharmaceutical companies immediately started designing a vaccine, using many of the available platform technologies, either proven or innovative. A few days later, two companies who had been developing a pioneering new technology, mRNA, had designed their first vaccine candidate: Moderna in the US and BioNTech in Germany. This first step had to be followed by an enormous amount of work to confirm the safety and effectiveness of each vaccine, culminating in a successful phase 3 human clinical trial on over 30,000 patients. At the same time, companies had less than 11 months to build a supply chain able to deliver between 50 and 100 million doses per month of each successful vaccine, while all the infrastructure to administer that level of inoculations was simultaneously being prepared. What made the accelerated delivery time possible for the vaccines was the decision by OWS to focus on being an enabler of industry innovation and execution without trying to control all aspects of the execution itself. In effect, the US government was underwriting the development and manufacturing risk for a number of vaccines and antibody treatments. Companies could start executing activities in parallel, because they no longer had to minimize those risks. By agreeing in advance to purchase a very large number of doses of vaccine, before having evidence of safety and effectiveness, the US government removed the biggest financial risk for the industry, effectively pulling out all the stops that would typically slow down development and manufacturing. The same approach was taken with monoclonal antibody therapies. This was extremely impactful, especially when combined with targeted support actions to remove key constraints and accelerate clinical development and supply chain setup and manufacturing. Together the recommendation to select three platform technologies (mRNA, viral vector, and protein sub-unit) and two programs per platform (Pfizer-BioNTech and Moderna, J&J and AstraZeneca, Sanofi and No-vavax). On the therapeutics side, the Regeneron and Eli Lilly antibody cocktails were initially selected, but screening for additional candidates to support (also in different therapeutic segments, such as small molecule antiviral) continued throughout the program. This ultimately led to identifying and supporting another antibody from AstraZeneca, as well as the Merck-Ridgeback and Pfizer antivirals. The acceleration of the clinical program required the activation of a very large number of clinical centers, strategically selected to provide the necessary mix of patient age groups, ethnicity, and risk profiles to ensure that the safety and effectiveness profile could be appropriately assessed. Leveraging the NIH network was instrumental for that purpose. MANUFACTURING The operation worked with the US Department of Justice (DOJ) to enable the exchange of capacity information between manufacturers, with the purpose of assessing potential manufacturing collaborations for COVID-19 treatments. The DOJ issued an opinion on 23 July 2020, stating that such exchanges of information for the purpose of increasing supply of COVID-19 therapies would not harm but help consumers, opening the door for collaborations between Genentech and Regeneron, Amgen and Eli Lilly, and Merck and J&J. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response in HHS had developed partnerships with two companies, and started construction of general-purpose capacity to manufacture biodefense countermeasures over the past several years. That capacity had never been finalized or started up, and had never received regulatory approval. The facilities existed, but we lacked most of the equipment and there was no organization to operate them. In all, five plants in the US supported those four programs, with two of the five plants shared by two programs each. It was not an ideal situation, but it could work. Initial assessments of these facilities pointed to the lack of experience in their staff as the major risk to execution, and not surprisingly, that was in deed the biggest challenge the program initially encountered from a manufacturing standpoint. To successfully manufacture any product, you need the process, the equipment, the materials, and a trained organization. The one thing we struggled with the most to accelerate was the selection, hiring, and training across the board in all of the facilities involved. Many times we deployed a provision in the Defense Production Act (DPA), which allows the government to request priority fulfillment of its orders to the government and its contractors. This provision was administered by the DoD personnel in OWS. Material procured under the DPA can only be used to fulfill government orders and must be used in the US. This was a very powerful tool, and we were extremely careful in its use, monitoring not only the delivery to OWS contractors but also the impact that this prioritization was having within the broad pharmaceutical supply chain. We worked in close contact with the FDA Drug Shortage Staff within the Center for Drugs and Evaluation and Research (CDER) to find alternative sources for every situation that could have led to potential shortages, and I can honestly say we prevented many crises this way. When we needed the support of foreign technicians for the qualification and startup of filling lines or other critical equipment, we worked with the Department of State to ensure the timely issuance of visas. Early in the program, we made a decision to install a “person in the plant” in each critical node of our supply chain where the antigen was manufactured and the fill-finish was happening. These individuals were majors from the DoD and expert supply chain professionals. We briefly trained them on the uniqueness of vaccine manufacturing, and they were dispatched at a moment’s notice for a nine-month assignment. DISTRIBUTION Distribution of the vaccines was flawlessly organized by the DoD logistics team with OWS. The criteria to allocate and distribute the vaccine were decided by the board. We partnered with McKesson, UPS, and FedEx to establish distribution centers and a next-day air delivery system to ensure chain of custody as well as cold-chain integrity. A logistics “war room” and control tower were set up on the second floor of the HHS building, and a system to collect data on inventory and immunization from all states and jurisdictions was developed in record time. This system was called Tiberius, and it allowed visibility and a single source of information for all logistics operations. The team also had to provide each vaccine administration center with all the ancillary materials needed for a successful vaccination campaign. This included syringes—which were different for different vaccines gloves—sanitizing pads, CDC vaccine cards and other items, in quantities to match the number of doses shipped. For every vaccine supply chain, there was a matching supply chain to provide the kits customized for that specific vaccine. From a logistics perspective, the most critical vaccine was the Pfizer product, which had to be stored in dry ice at -80ₒ C. Each shipper contained a GPS monitor that allowed tracking in real time, and a resupply process for dry ice. Nothing was left to chance. The Center for Biologics Evaluation and Research, the FDA division responsible for vaccine review, allowed companies to execute rolling submissions and the review to proceed in parallel with the submission. This flexibility, however, did not extend to any requirement for the quality and safety of the vaccines: At no point in time did I see any compromise on those critical aspects. In addition to the clinical package with the phase 3 data including the safety follow-up, the submission package needed to include data from the validation lots. And, assuming success, we also wanted to be in a position to have inventory available and start the immunization campaign as soon as the FDA completed their review and issued the EUA. The schedule did not allow for much inventory buildup in preparation for approval, and it was a startup, after all, with all the risks interconnected. In every plant, people were working extended shifts and weekends in order to meet deadlines, with tremendous personal commitment despite the risks. Of course, as in every startup, not everything was smooth sailing. We were always running hand to mouth with materials, and any issue with the quality of a component would have had an immediate impact on the manufacturing schedule. The Army logistics team was tracking all shipments in real time, and at times we had to invite some CEOs to phone conferences with Perna when we saw a risk to a delivery date. Some equipment failed, and we had to rush replacements, and so did some of the materials. If you look strictly at the mission OWS took on, it was certainly successfully accomplished, with two safe and effective vaccines approved before the end of the year, and a third one by the end of Q1 2021. Of the six vaccines, five have obtained approval in the US or Europe, and they have been administered in several countries. The sixth has recently announced positive clinical results, and it will soon be submitted for approval. That is a remarkable achievement for our industry and for science, and it is already making a difference in the world. And finally, I have learned how critical it is to prepare for the next pandemic. Because there will be another one. We don’t know when and where it will emerge, but it will. That, we can all count on. https://ispe.org/pharmaceutical-engineering/may-june-2022/special-report-operation-warp-speed-view-inside
@Amy31129057 - QuestionIt
If you haven't already @RandPaul @RobertKennedyJr @SenRonJohnson l believe looking into the MILKEN INSTITUTE "THINK TANK" is warranted. Page 22 of 27 should tell you what you need to know! For those that do not know, The Milken Institute is an independent economic think tank based in Santa Monica, California, with offices in Washington, D.C., New York, Miami, London, Abu Dhabi, and Singapore. It publishes research and hosts conferences that apply market-based principles and financial innovations to social issues in the US and internationally. The institute is a 501(c)(3) nonprofit organization and presents itself as nonpartisan and non-ideological. https://milkeninstitute.org/sites/default/files/2021-06/A%20Global%20Early%20Warning%20System%20for%20Pandemics.pdf https://en.wikipedia.org/wiki/Milken_Institute
@Amy31129057 - QuestionIt
FasterCures ~ MILKEN INSTITUTE A GLOBAL EARLY WARNING SYSTEM FOR PANDEMICS 🤔 Researchers now estimate that the SARSCoV-2 virus was likely circulating undetected for some time before the first outbreak was reported in Wuhan, China. Three multilateral agencies within the United Nations (UN)—the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for Animal Health (OIE)—exemplify strong institutional capacity for global surveillance. The WHO conducts indicator-based surveillance for specific diseases, such as seasonal, pandemic, and zoonotic influenza monitoring, through its Global Influenza Surveillance and Response System (GISRS). GISRS consists of WHO Collaborating Center and Essential Regulatory Laboratories across the globe. “Global influenza surveillance has been conducted through WHO’s Global Influenza Surveillance and Response System (GISRS) since 1952. GISRS is a system fostering global confidence and trust for over half a century, through effective collaboration and sharing of viruses, data and benefits based on Member States’ commitment to a global public health model. The mission of GISRS is to protect people from the threat of influenza by continuously functioning as a: • global mechanism of surveillance, preparedness and response for seasonal, pandemic and zoonotic influenza; • global platform for monitoring influenza epidemiology and disease; and • global alert for novel influenza viruses and other respiratory pathogens. GISRS currently comprises institutions in 123 WHO Member States. Global Early Warning System for Major Animal Diseases, including Zoonoses (GLEWS) is a contributor to GF-TADs. A joint initiative among the OIE, FAO, and WHO, GLEWS coordinates the risk assessment of zoonotic threats, data sharing, and initiation of public health responses. It works alongside existing FAO and WHO surveillance systems to strengthen their early warning efforts and provide a network of stakeholders to address such actions. Now is the catalytic moment to mobilize existing surveillance systems with stronger global coordination to detect pre-pathogenic events as early as possible. I will let you read the full 27 pages for all the details. It discusses “PREDICT, a project of USAID’s Emerging Pandemic Threats (EPT) program, “The Global Virome Project (GVP) is an innovative 10-year partnership, s Infection Innovation Consortium (iiCON), global coordination, the Program for Monitoring Emerging Diseases – ProMED, Africa CDC Institute of Pathogen Genomics, through the Africa Pathogen Genomics Initiative (Africa PGI), and lastly finances and who can forget “CEPI [The Coalition for Epidemic Preparedness Innovations] was founded in Davos by the governments of Norway and India, the Bill & Melinda Gates Foundation, Wellcome, and the World Economic Forum. @RandPaul https://milkeninstitute.org/sites/default/files/2021-06/A%20Global%20Early%20Warning%20System%20for%20Pandemics.pdf
@Amy31129057 - QuestionIt
Who remembers Cayman Chemical SM-102? You know the ingredient added to the mRNA vaccine for Covid and used with the PCR. https://www.korambiotech.com/en/company/brand-and-suppliers/cayman-chemical/ https://www.caymanchem.com/product/34337/alc-0315
@Amy31129057 - QuestionIt
Who is Koram Biotech Corp~ Check out their CEO & Founder along with their president. 😏 Matthew I. Hyun CEO & Founder Matthew has been Chief Executive Officer of Koram Biotech Corp since 1988. Prior to founding the company in 1988, Matthew worked as a research scientist at the National Cancer Institute (NCI) of National Institute of Health (NIH) in the U.S. Edward W. Hyun President Edward joined Koram Biogen Corp in 2014 as a managing director. Before joining the company, Edward held various roles of increasing responsibilities across several countries and regions at GlaxoSmithKline (GSK), including Regional Director, Asia Pacific & Emerging Markets and Global Pharmaceutical and Consumer Healthcare Collaboration Lead. Prior to GSK, he worked at Amgen and biotech start-ups in California. He has an MBA from Georgetown University and holds a degree in biochemistry from University of Wisconsin, Madison. He also worked in various research roles at Human Embryonic Materials (HEM) Research, Biocon and Litton Bionetics. He has a degree in Clinical Pathology from Korea University. For more than three decades, Koram has provided Korean researchers and life sciences manufacturers with high quality research reagents, certified biological & molecular reference materials and customized GMP solutions as well as laboratory consumables and instruments to accelerate biological understanding and enable breakthrough research. Koram, one of Korea’s largest life science distributors, is committed to helping our customers achieve their research objectives with comprehensive technical support, responsive customer care and reliable cold chain logistics. With the extensive sales network of 8 branch offices and 8 distributors, Koram Biotech and Koram Biogen have assisted and supported Korean researchers in academia, gov’t institutions and hospitals as well as biotech and pharmaceutical companies for more than three decades. Principal Suppliers & Business Partners include: • American Type Culture Collection (ATCC) • Cell Signaling Technology (CST) • New England Biolabs (NEB) • Santa Cruz Biotechnology (SCBT) • OriGene Technologies • Proteintech • Eppendorf • Emulate • Cayman Chemical & Matreya • LGC SeraCare Clinical Diagnostics, KPL, Native Antigen Company • Eurogentec & Anaspec, Kaneka Company • Signalchem Biotech & Diagnostics • Tonbo Biosciences, Cytek Company • ZeptoMetrix, Antylia Scientific Company • Cellecta • Labcon • Logos Biosystems And a whole lot more... Life Sciences Distributor, Korea, CSO, high quality research reagents, biological material, microorganism, GMP reagents, cGMP service, certified reference materials, IVD molecular controls, biochemicals, plastic labware, benchtop instruments , cell line, primary cell, virus, bacteria, cell culture media, FBS, stem cell, nucleic acid, primary antibody, monoclonal antibody, polyclonal antibody, secondary antibody, qPCR, RT PCR, protein modifying tools, restriction enzymes, modifying enzymes, polymerase, NGS, next generation sequencing, cDNA clones, RNAi, siRNA, gene silencing, CRISPR, vectors, lenti particle, lentivirus, recombinant protein, cytokines, growth factors, ELISA kits, assay kits, kinases, RNA synthesis reagents, and microbiome, organoid, organ chip, organ on a chip. https://www.korambiotech.com/en/our-customers/ https://www.korambiotech.com/en/company/our-leadership/ https://www.korambiotech.com/en/company/brand-and-suppliers/ https://www.korambiotech.com/company/brand-and-suppliers/american-type-culture-collection-atcc/
@Amy31129057 - QuestionIt
Who is Alex Zhavoronkov- He is the co-founder and CEO of Insilico Medicine, a company dedicated to drug discovery for cancer and aging located at the Emerging Technology Centers of the Johns Hopkins University. Zhavoronkov earned two bachelor's degrees at Queen's University in computer science and commerce. He has a master's in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from Moscow State University. Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine, and aging economics. He is the director of the Biogerontology Research Foundation, a UK-based think-tank for aging research, and is also the director of the International Aging Research Portfolio, an open-access repository of biomedical grants. He is the adjunct professor at the Moscow Institute of Physics and Technology and heads the laboratory of regenerative medicine at the Federal Clinical Research Center for Pediatric Hematology, Oncology and Immunology in Moscow. I encourage you to watch this video. He discusses medicine of the future, aging, population, and even mentions Trump and voting. https://youtu.be/W8ErHeSFOKM https://alchetron.com/Alex-Zhavoronkov
@Amy31129057 - QuestionIt
Is this why Pfizer didn't want us to know about the mRNA for 75 years? @DecentFiJC @RandPaul @RepThomasMassie @LmBubba @Leeshotfury1966 READ THE ENTIRE THREAD! Jan. 14, 2020 – Insilico Medicine is pleased to announce that it has entered into a research collaboration with Pfizer Inc. (NYSE: PFE) to utilize Insilico’s machine learning technology and proprietary Pandomics Discovery Platform with the aim of identifying real-world evidence for potential therapeutic targets implicated in a variety of diseases. “Insilico is advancing its latest target identification systems utilizing machine learning, generative biology methods, and synthetic data generation pipelines, and we are pleased to be collaborating with Pfizer on its target identification efforts,” said Alex Zhavoronkov, PhD, founder, and CEO of Insilico Medicine. “We look forward to working with Insilico as Pfizer continues to explore new technologies that may be able to help us identify targets and biomarkers that could assist in our discovery programs, and potentially lead to breakthrough therapeutics for patients with unmet medical needs,” said Morten Sogaard, Vice President, Target Sciences, Pfizer. In September 2019, Insilico Medicine announced a $37 million round led by prominent biotechnology and AI investors. https://www.pfizer.com/news/press-release/press-release-detail/insilico-enters-research-collaboration-pfizer-inc-explore
@Amy31129057 - QuestionIt
Oh, and @DecentFiJC don't forget the best part.... 23andMe is featured on the World Economic Forum website. 😏 https://www.weforum.org/organizations/23andme/
@Amy31129057 - QuestionIt
Where shall I begin...... Your DNA, Censorship, Standford @DecentFiJC 23andMe confirms hackers stole ancestry data on 6.9 million users (December 4, 2023) Before we go into the details here is a little back infor for you. Sergey Brin, Co-Founder of Google and the president of Alphabet Inc (Brin began his graduate study in computer science at Stanford University on a graduate fellowship from the National Science Foundation, receiving an M.S. in computer science in 1995. As of 2008, he was on leave from his PhD studies at Stanford). Brin was married to Anne Wojcicki who is the Co-founder of 23andMe (who have since divorced), who happens to be the sister of Susan Wojcicki of Youtube. Wojcicki has worked in the technology industry for over twenty years Their parents are Esther Wojcicki (née Hochman), an educator and journalist, and Stanley Wojcicki, a Polish-born physics professor emeritus at Stanford University. Remember Larry Page, also a Co-founder of Google (involved in the Jeffrey Epstein scandal and has been missing since May of 2023) was working with Bill Gates on the Uni 23andMe spokesperson Katie Watson confirmed that hackers accessed the personal information of about 5.5 million people who opted-in to 23andMe’s DNA Relatives feature, which allows customers to automatically share some of their data with others. The stolen data included the person’s name, birth year, relationship labels, the percentage of DNA shared with relatives, ancestry reports and self-reported location. 23andMe also confirmed that another group of about 1.4 million people who opted-in to DNA Relatives also “had their Family Tree profile information accessed,” which includes display names, relationship labels, birth year, self-reported location and whether the user decided to share their information, the spokesperson said. (23andMe declared part of its email as “on background,” which requires that both parties agree to the terms in advance. TechCrunch is printing the reply as we were given no opportunity to reject the terms.) https://techcrunch.com/2023/12/04/23andme-confirms-hackers-stole-ancestry-data-on-6-9-million-users/ https://fiercepharma.com/vaccines/thinking-developing-a-truly-universal-flu-vaccine-bill-gates-and-larry-page-challenge-you https://businessinsider.com/us-virgin-islands-cant-find-larry-page-subpoena-epstein-case-2023-5?op=1… https://en.wikipedia.org/wiki/Sergey_Brin https://en.wikipedia.org/wiki/Susan_Wojcicki https://en.wikipedia.org/wiki/Anne_Wojcicki https://en.wikipedia.org/wiki/Larry_Page
@Amy31129057 - QuestionIt
@DecentFiJC I should note On February 16, 2023, Susan Wojcicki announced her resignation from YouTube via a company blog post.
@Amy31129057 - QuestionIt
Perhaps people didn't hear me...... The National Science Foundation funded 2 grants to spy on you about the pandemic while using TWITTER University of Oklahoma Initial Amendment Date: March 30, 2020 Start: April 1, 2020 End Date: March 31, 2021 (Estimated) $200,000.00 PURDUE UNIVERSITY Initial Amendment Date: May 11, 2020 May 15, 2020 April 30, 2022 (Estimated) $57,999.00 https://www.nsf.gov/awardsearch/showAward?AWD_ID=2026763&HistoricalAwards=false https://www.nsf.gov/awardsearch/showAward?AWD_ID=2027524
@Amy31129057 - QuestionIt
COVID SPY STATE AND TWITTER~ Hey @elonmusk @RandPaul @SenRonJohnson @RepThomasMassie @Leeshotfury1966 @I_Am_JohnCullen Visual Analytics for Decision-Making During Pandemics (November 2020) To address this gap, members of our team are currently engaged in a continuously updated behavioral monitoring survey, focused on COVID-19 related beliefs and behaviors in the U.S. (NSF RAPID Grant 2026763), as well as analysis of Twitter data related to COVID-19. We are also collaborating with researchers at Purdue University, University of West Florida, and Arizona State University to explore social mobility data for more effective measures of the impact of NPIs (NSF RAPID grant 2027524). Since early 2020, part of our team at the University of Oklahoma National Institute for Risk and Resilience (NIRR) has pursued several projects focused on the COVID-19 pandemic. In January, they implemented a broad collection of social media posts from Twitter's API using a basket of search terms. That collection includes approximately 300 million posts, amounting to half a TB of data. These data are used to identify the evolving array of COVID-19 communication networks using the Louvain community detection algorithm on the largest connected component of the retweet network drawn from the most prolific accounts (minimum three tweets per day) to prune the network. Weekly samples are drawn from the top tweets (according to PageRank scores) within each cluster and categorized by human coders to track the content of social narratives. The resulting weekly network snapshots reveal a polarized network structure that reflects current divisions in American politics. Interestingly, the political right displays a remarkable level of stability while the left has exhibited more dynamic cluster with the larger moderate left gradually incorporating a smaller progressive group over time. A common characteristic of these network communities is the presence of dense clusters of users around popular politicians and media figures with relatively short communication pathways that enable the rapid transmission of information. Of particular interest are patterns of misinformation about the nature, transmission, effects, and protective actions associated with COVID-19 within each of the more stable network clusters. Preliminary analysis of the network structure and content of the most prominent accounts and tweets has found a number of coherent misinformation narratives, including conspiracy theories, cures, and other statements about COVID-19 that are based on verifiably false claims, that have spread throughout the social media landscape. These narratives include claims that COVID-19 is the product of a shadowy conspiracy of powerful individuals, the virus originated as a bioweapon, COVID-19 is no worse than seasonal flu, and hydroxychloroquine is an effective cure. Among the false narratives identified, a disproportionate number of these misleading claims regularly have appeared within the conservative right community on social media, but it remains to be seen if this flow of misinformation will shift. Starting in mid-March, a rolling nationwide survey, with weekly representative subsamples, was implemented to track the patterns of awareness of and belief about the COVID-19 misinformation identified in the Twitter social media collection. The survey permits assessment of the ways in which social media misinformation (and efforts to counter that misinformation) affect evolving public concern about and response to the pandemic. A key interest is in understanding changes over time in public trust for experts and individual willingness to engage in protective actions. This work was supported by the National Science Foundation under Grant SES-2026763 and Grant 2027524. The authors would like to thank Dr. H. Jenkins-Smith for his contributions. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295915/
@Amy31129057 - QuestionIt
Everyone watched the Johns Hopkins map during the pandemic.....when they should have been listening to @I_Am_JohnCullen who built the map many years ago! 07-Apr-2020 Launched on January 22, this real-time tracking map is created and maintained by Lauren Gardner, an associate professor in the Department of Civil and Systems Engineering at Johns Hopkins University, together with two Chinese students, Dong Ensheng and Du Hongru, first-year PhD students at the university's Center for Systems Science and Engineering. "On January 21, we (Dong and his tutor) reached an agreement to make the interactive dashboard. I spent about seven to eight hours that night to complete the first edition. Then my tutor posted this dashboard on Twitter at around 11 a.m. on January 22," said Dong. Their original intention to create this dashboard was to collect data for academic research. However, with the development of the epidemic, it has become the most cited source of epidemic data for government officials, public health scholars and mainstream media in many countries. Updating and operating this website has become Dong's "main business." Dong and his tutor updated the map data manually twice a day, in the morning and evening. But as the pandemic unfurled, they found that manual updates were unsustainable, so they decided to automate parts of it and invited Du to work with them. Joining the team on February 1, Du's main work is to write code for automatic updates and compare the data they collected with the numbers released by the World Health Organization (WHO), ensuring data consistency and accuracy. 🙄 "The most difficult thing is that these data sources are all in different formats and often different languages. We need to gather each data source, organize and adjust them into the format we need, then upload it to the dashboard," said Du. "Basically, every time our server goes down, it's when there is a huge change in the epidemic," Dong told a local Chinese media outlet. He said that there have been three peaks since the COVID-19 tracking map was launched. "The first time was when China changed their method for diagnosing cases. People found that the number of confirmed cases suddenly increased, and many of them went to our website. The second time was when the coronavirus broke out in Italy, and many Italian people flooded the website. Now is the third climax, mainly due to the outbreak in the United States," Dong explained. https://news.cgtn.com/news/2020-04-07/Who-has-the-most-high-profile-COVID-19-tracking-map--PuDYW0JZa8/index.html
@Amy31129057 - QuestionIt
We have Mark Zuckerberg with Instagram- Instagram algorithm boosted ‘vast pedophile network,’ alarming report claims (June 2023). Instagram’s recommendation algorithms linked and even promoted a “vast pedophile network” that advertised the sale of illicit “child-sex material” on the platform, according to the findings of an alarming report. Instagram allowed users to search by hashtags related to child-sex abuse, including graphic terms such as pedowhore, preteensex, pedobait and mnsfw — the latter an acronym meaning “minors not safe for work,” researchers at Stanford University and the University of Massachusetts Amherst told the Wall Street Journal. The hashtags directed users to accounts that purportedly offered to sell pedophilic materials via “menus” of content, including videos of children harming themselves or committing acts of bestiality, the researchers said. Some accounts allowed buyers to “commission specific acts” or arrange “meet ups,” the Journal said. https://nypost.com/2023/06/07/instagram-algorithm-boosted-vast-pedophile-network-report/ https://www.wsj.com/articles/instagram-vast-pedophile-network-4ab7189?mod=hp_lead_pos7
@Amy31129057 - QuestionIt
Stay with me on this one~ Thorn Launches Silicon Valley Innovation Lab To Fight Child Sexual Exploitation With Technology Google, Facebook, Microsoft, Expedia, IAC, Sabre, Twitter, Amazon Web Services and Pinterest Partner with Thorn (2015) Thorn: Digital Defenders of Children, a non-profit organization dedicated to driving technology innovation to fight child sexual exploitation, announced today the launch of The Thorn Innovation Lab in Silicon Valley. The Lab will serve as a physical think tank for a team of engineers and data scientists to research technologies, create partnerships and build innovative technology solutions to fight child sexual exploitation. The Thorn Innovation Lab has partnered with tech industry giants including Google, Facebook, Microsoft, Expedia, IAC, Sabre, Twitter, Amazon Web Services (AWS) and Pinterest. The companies will participate through financial donations and by providing expertise, guidance and engineering support. The Lab's initial areas of focus include child sex trafficking, dark web child abuse and exploitation, and social platform cybersafety. The Lab is a natural next step, given Thorn's deep roots in Silicon Valley. In 2010, with the leadership of Ron Conway, founder of SV Angel, Thorn created a Technology Task Force to focus on collaboration and information sharing to improve the use of technology to combat child sexual exploitation. Thorn has also created a Technology Task Force — a group of more than 25 technology companies that collaborate on technology initiatives to fight child sexual exploitation. Participating companies include Google, Facebook, Salesforce, Microsoft, Symantec, SV Angel, Twitter, Expedia, Connotate, Irdeto, Mozilla, Digital Reasoning, Palantir, Sabre, Pinterest, Amazon Web Services (AWS) and others. For more information on Thorn, please visit http://wearethorn.org, follow us on Twitter @THORN and http://facebook.com/wearethorn. #sextrafficking #humantrafficking #pedophilia #pedophile https://prnewswire.com/news-releases/thorn-launches-silicon-valley-innovation-lab-to-fight-child-sexual-exploitation-with-technology-300177346.html
@Amy31129057 - QuestionIt
We have Peter Thiel of Palatir-
@Amy31129057 - QuestionIt
Interesting~ Palantir & the National Center for Missing & Exploited Children (NCMEC) Peter Theil was Palantir's largest shareholder as of 2014- The same Billionaire Peter Thiel reportedly had 'several meetings' scheduled with Jeffrey Epstein, according to email records. Peter Thiel likely met with the convicted sex offender Jeffrey Epstein "several" times in 2014, according to a recent report from The New York Times. The email records were obtained through an information request in the US Virgin Islands lawsuit against Epstein's estate, according to the Times. The lawsuit was settled last year after Epstein's estate agreed to pay the US Virgin Islands more than $105 million over claims Epstein had used an island in its territory for a sex-trafficking operation. The publication said it isn't known whether Thiel attended all of the meetings mentioned in the emails because some of them were marked as "TBD." Thiel did not respond to a request for comment from Insider and a spokesperson for the billionaire declined to comment for the Times. Since 2010, Palantir has partnered with NCMEC, providing our data integration software in support of its mission to help find missing children. https://www.palantir.com/ncmec/ https://www.businessinsider.com/peter-thiel-may-have-multiple-meetings-jeffrey-epstein-report-2023-5?op=1 https://blog.palantir.com/fighting-child-exploitation-with-big-data-86868bad559e https://youtu.be/4oV7NDnv6Gc
@Amy31129057 - QuestionIt
Obama left Howard Varmus in the middle and Francis Collins to the right. Who is Howard Varmus~ In August of 2020, Francis Collins, head of the US National Institutes of Health, emailed his predecessor, Varmus. Copying in Anthony Fauci, Collins wanted their opinions on a specific lab escape hypothesis, our Mojiang Miner Passage theory of the origin of the virus. Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center. He was also the director of the National Institutes of Health from 1993 to 1999 and the 14th Director of the National Cancer Institute from 2010 to 2015, a post to which he was appointed by President Barack Obama. Near the end of his tenure as NIH director, Varmus became a champion of ways to more effectively use the Internet to enhance access to scientific papers. The first practical outcome was the establishment, with David Lipman of the National Center for Biotechnology Information at NIH, of PubMed Central, a public digital library of full-length scientific reports; in 2007, Congress directed NIH to ensure that all reports of work supported by the NIH appear in PubMed Central within a year after publication. Varmus has been a frequent advisor to the US government, foundations, academic institutions and industry. Currently, he serves as a member of the Secretary of Energy's advisory board, the Global Health Advisory Board at the Bill and Melinda Gates Foundation, the board of directors of the International Biomedical Research Alliance, the Lasker Foundation Prize Jury, and the Scientific Advisory Board of the Broad Institute at Harvard and MIT, and he chairs advisory groups for the Faculty of 1000 and the Global Alliance for Genomics and Health. In the past, he was chairman of the Grand Challenges in Global Health at the Gates Foundation, a member of the World Health Organization's Commission on Macroeconomics and Health, and an advisor to Merck & Co., Chiron Corporation, Gilead, and Onyx Pharmaceuticals. He has been chair of the World Health Organization's Science Council since its founding in 2021. Varmus has been married since 1969 to Constance Louise Casey, a journalist and science writer. https://www.nih.gov/about-nih/what-we-do/nih-almanac/harold-e-varmus-md https://www.fic.nih.gov/News/GlobalHealthMatters/may-june-2021/Pages/harold-varmus-leads-who-science-council.aspx https://jonathanlatham.net/faucis-covid-origin-swat-team-versus-the-mojiang-miner-passage-theory/ https://en.wikipedia.org/wiki/Harold_E._Varmus
@Amy31129057 - QuestionIt
PAY ATTENTION~ Eleven days before President Trump's January 20, 2017 inauguration, the #Obama #Biden and John Holdren (Director of the White House Science and Technology Policy -OSTP) recommended the U.S government lift restrictions on gain of function research to enhance a pathogen's virulence and/or transmissibility to produce a PANDEMIC pathogen. The HHS Director at that time was Sylvia Matthews Burwell, a former Global Development Program and Chief Operating Officer of the Bill & Melinda Gates Foundation. “It has been a great pleasure to work with Sylvia during her time as President of Global Development at the Bill & Melinda Gates Foundation,” says Kofi Annan, Chairman of the Alliance for a Green Revolution in Africa (AGRA) and former Secretary-General of the United Nations. During her tenure the foundation’s grantmaking grew during by 40 percent, to $1.5 billion per year, while staff grew by 50 percent, to 350. She also oversaw the opening of the foundation’s first office outside of Seattle, in Washington, D.C. According to U.S. Army Colonel Dr. Lawrence Selling (Ret.) Trump was never alerted that the U.S. government's restriction on lethal gain of function research had been lifted by Francis Collins. https://www.phe.gov/s3/dualuse/Documents/P3CO-FinalGuidanceStatement.pdf https://www.gatesfoundation.org/Ideas/Media-Center/Press-Releases/2011/08/President-of-Global-Development-Program-to-Step-Down https://www.wvencyclopedia.org/articles/2427
@Amy31129057 - QuestionIt
Pay Attention~ What is the Hemisphere Project- (See the link below for the letter from Ron Wyden of Oregon, November 20, 2023) A mass surveillance program conducted by US telephone company AT&T and paid for by the White House Office of National Drug Control Policy and the Drug Enforcement Administration (DEA). AT&T collects metadata relating to all calls routed through AT&T’s exchanges, including calls made from non-AT&T handsets. The data collected include the phone numbers of the caller and recipient, the date, time and length of calls and, in some cases, a caller’s location. An estimated four billion new call detail records are created on AT&T’s database every day, though it is possible for a call to be recorded more than once. The DAS program, formerly known as Hemisphere, is run in coordination with the telecom giant AT&T, which captures and conducts analysis of US call records for law enforcement agencies, from local police and sheriffs’ departments to US customs offices and postal inspectors across the country, according to a White House memo reviewed by WIRED. Records show that the White House has provided more than $6 million to the program, which allows the targeting of the records of any calls that use AT&T’s infrastructure—a maze of routers and switches that crisscross the United States. The program was likened to proposals made by legislators after the disclosure of PRISM, in particular one by Representative Adam Schiff who had called for a "look at changing the telephone metadata program by having phone companies retain their own data, rather of [sic] the government." https://www.wyden.senate.gov/imo/media/doc/wyden_hemisphere_surveillance_letter_112023.pdf https://en.wikipedia.org/wiki/Hemisphere_Project https://www.eff.org/cases/hemisphere https://www.eff.org/cases/hemisphere
@RepDanBishop - Rep. Dan Bishop
.@WIRED reports on a government program that allows officials to access phone records of Americans who aren't suspected of any crime. Government surveillance and censorship aren't isolated to our current moment. We must always fight hard for our freedoms. https://www.wired.com/story/hemisphere-das-white-house-surveillance-trillions-us-call-records/
@Amy31129057 - QuestionIt
Interesting~ The Trilateral Commission~ A nongovernmental international organization aimed at fostering closer cooperation between Japan, Western Europe and North America. The Trilateral Commission is headed by an executive committee and three regional chairs representing Europe, North America, and the Asia-Pacific region, with headquarters in Paris, Washington, D.C., and Tokyo, respectively. Meetings are held annually at locations that rotate among the three regions; regional and national meetings are held throughout the year. The Trilateral Commission represents influential commercial and political interests. As of 2021, there were roughly 400 members, including leading figures in politics, business, media, and academia. Each country within the three regions is assigned a quota of members reflecting its relative political and economic strength. Other founding members included Alan Greenspan and Paul Volcker, both later heads of the Federal Reserve System. *Take a look at the members at the link below. 🤔 https://en.wikipedia.org/wiki/Trilateral_Commission
@Amy31129057 - QuestionIt
Glad to see the Brownstone Institute is finally catching up as I mentioned this back in June. @RandPaul @SenRonJohnson @RepThomasMassie The FDA’s Ties to the Gates Foundation (October 20, 2023) In 2017, the US Food and Drug Administration (FDA) entered into a memorandum of understanding (MOU) with the Bill & Melinda Gates Foundation. Under the MOU, the two entities agreed to share information to “facilitate the development of innovative products, including medical countermeasures,” such as diagnostics, vaccines, and therapeutics to combat disease transmission during a pandemic. The FDA has MOUs with many academic and non-profit organizations, but few have as much to gain as Bill Gates, who has invested billions into pandemic countermeasures. Experts are concerned the Gates Foundation could have undue influence over the FDA’s regulatory decisions of these countermeasures. David Gortler, an ex-senior adviser to the FDA commissioner between 2019 and 2021, says he is “suspicious” of the MOU. Gortler, now a fellow at the Ethics and Public Policy Center in Washington, DC, explained that normally, meetings between developers and regulators are supposed to be an official part of the public record and subject to Freedom of Information Act requests. The Gates Foundation, which holds shares in a range of drug companies including Merck, Pfizer, and Johnson & Johnson, is now credited with wielding significant influence over the direction of the global response to the pandemic, saying its goal is to “vaccinate the entire world” with a covid-19 vaccine. Financial contributions to the media have garnered Gates favorable news coverage, boasting on the foundation’s website it committed almost $3.5 million to the Guardian in 2020 – 2023. The UK medicines regulator – the MHRA – disclosed it took approximately $3 million in funding from the Gates Foundation in 2022, which would span across several financial years. https://brownstone.org/articles/fda-ties-to-gates-foundation/
@Amy31129057 - QuestionIt
The FDA & The Bill and Melinda Gates Foundation~ The Food and Drug Administration (FDA) and the Bill & Melinda Gates Foundation (BMGF) (each a “Party” and collectively the “Parties”) share interests in scientific progress related to regulatory science and regulatory capacity building in support of advancing global public health. This memorandum of understanding (MOU) establishes a framework for collaboration between FDA and the BMGF to facilitate existing and new mutually agreed upon programs and activities and to carry out their common goal to improve public health by stimulating and fostering medical product innovation and enabling medical product development. Regulatory Science. FDA and BMGF may collaborate and share information, as appropriate, on research concerning enabling technologies—including advancing the availability of tools of regulatory science—that will facilitate the development of innovative medical products, including medical countermeasures. For the purposes of this MOU, regulatory science includes the development and qualification/validation of new test methods, reference materials, or reagents for preclinical and clinical safety/toxicology assessments and for the assessments of product efficacy, safety, or quality, post-market safety, and effectiveness methods development. Expansion of regulatory capacity building. FDA and BMGF may collaborate in regulatory systems capacity building activities, such as FDA provision of technical input to BMGF funded efforts to address regulatory systems challenges associated with advancing global public health. For the purposes of this MOU, regulatory systems capacity building includes providing support to country-led initiatives to optimize the technical, scientific, and regulatory capacity of foreign government national and regional regulatory agencies and their respective relevant industries. Global public health. FDA and BMGF may collaborate on the identification of global public health challenges and the development of solutions that have the greatest potential value to global public health. FDA and BMGF anticipate the activities covered by this MOU will involve workshops, meetings, scientific collaborations, and other communications between officials of FDA and BMGF. Each Party may change its point of contact upon reasonable written notice to the other Party. This MOU becomes effective upon the signature of authorized representatives of both Parties and remains in effect, unless otherwise terminated. @RandPaul https://www.fda.gov/about-fda/non-profit-and-other-mous/mou-225-17-019
@Amy31129057 - QuestionIt
The Universal Influenza Vaccine. @RandPaul @SenRonJohnson @RepThomasMassie At UW in Washington State no less~😏What would it be without Bill Gates-Back in April of 2019 Institute for Protein Design wins $45M in funding from TED’s Audacious Project- The five-year grant adds to funding that the institute receives from the likes of the Bill & Melinda Gates Foundation and the National Institutes of Health. Right now, the institute has about 100 people on its staff, “and we are going to be ramping that number up considerably,” Baker said. That fits right in with the mission of The Audacious Project, which was launched by TED’s organizers with support from The Bridgespan Group. The project pulls together philanthropic funds from a variety of contributors — including the Skoll Foundation, Virgin Unite and the Dalio Foundation — and distributes the money to boost bold ideas. (https://finance.yahoo.com/news/institute-protein-design-wins-45m-000003695.html) Advisory Board- Bryan White- was Co-founder and Chief Investment Officer of Quadra/Quellos and subsequently BlackRock. George Church, is a professor of genetics at Harvard Medical School and director of http://PersonalGenomes.org, which provides the world’s only open-access information on human genomic, environmental, and trait data. Robert M. Hershberg-is a Venture Partner with Frazier Life Sciences and was was the President and CEO of VentiRx Pharmaceuticals, a clinical-stage biopharmaceutical company, which he co-founded in 2006. Jeff Wilke-retired as Amazon’s CEO Worldwide Consumer in February 2021. During his more than 21 years as a corporate officer, he led Amazon’s retail and third-party stores, operations, marketing, Prime, and technology teams. Clara Wu Tsai-works closely with the Stanford University Neurosciences Institute https://www.ipd.uw.edu/ https://www.ipd.uw.edu/people/advisory-board/ https://www.ipd.uw.edu/people/faculty_and_staff/ https://x.com/UWproteindesign/status/1398301974798299138?s=20 https://newsroom.uw.edu/news/institute-protein-design-holds-ai-safety-summit https://finance.yahoo.com/news/institute-protein-design-wins-45m-000003695.html
@UWproteindesign - Institute for Protein Design
Dr. Anthony Fauci shared some news with Congress about our collaborative influenza vaccine research. Phase 1 trials are now underway! Paper is https://www.nature.com/articles/s41586-021-03365-x by @DanLikeProteins, @KingLabIPD, @kanekiyom, @BarneyGrahamMD, & many more.
@Amy31129057 - QuestionIt
Conversations with Mike Milken and Margaret Hamburg (April 2020) This is going to bite you in the a$$! The ability to sequence the genome of this virus quickly and then have it posted by a Chinese scientist for all the world to see did make it possible to move much more quickly towards the development of diagnostics and vaccines and to help us better understand the nature of this virus for the development of drugs. The ability to sequence the genome of this virus quickly and then have it posted by a Chinese scientist for all the world to see did make it possible to move much more quickly towards the development of diagnostics and vaccines and to help us better understand the nature of this virus for the development of drugs. It does take time to develop and test these products to make sure they actually work and to make sure that the benefits of these products, whether drugs or vaccines, will outweigh risks to patients, which we cannot discount. Efforts are underway to accelerate this process as much as possible. There are a lot of candidate vaccines that are now being developed, more than 50. In fact, one vaccine has broken all records, going from the first posting of the genome by the Chinese scientist to an actual injection of a candidate vaccine into a person in just a little over nine weeks. Margaret was a member of the Coalition for Epidemic Preparedness and Innovation [CEPI] as well as the Global Alliance for Vaccines and Immunization [GAVI]. prior to Covid. "And also recognizing that once we have a proven vaccine that's safe and effective against this novel coronavirus, we're going to want it in huge quantities." "The other point about trust and confidence is a key one because there is no doubt, whether we're talking about FDA or the Centers for Disease Control (CDC) or the National Institutes of Health (NIH), that we have the most sophisticated and expert scientists and medical and public health professionals of any place in the world" @RandPaul @RepThomasMassie @chiproytx @Complexity_CLS https://milkeninstitute.org/sites/default/files/2020-04/Conversations%20with%20MM%20-%20010%20Margaret%20Hamburg%20-%20April%209%2C%202020.pdf
@Amy31129057 - QuestionIt
Well isn't this special! Joseph Tsai-is a Taiwanese-Canadian billionaire business magnate, lawyer, and philanthropist. He is a co-founder and chairman of the Chinese multinational technology company Alibaba Group and owns the Brooklyn Nets of the American National Basketball Association (NBA), the New York Liberty of the Women’s National Basketball Association (WNBA), the San Diego Seals of the National Lacrosse League, and has interests in several other professional sports franchises. Tsai, whose net worth is currently around $10.1 billion even after Alibaba’s stock price dropped in summer 2021, has been a spokesman for Ma during his disappearance from the public eye. Politically, Tsai has maintained loyalty to the Communist Party, which holds power in China. In late March and early April 2020 during the COVID-19 pandemic, the Tsais donated 2.6 million masks, 170,000 goggles and 2,000 ventilators to New York. On 20 April 2020, they donated $1.6 million of medical supplies to hospitals in San Diego. Guess who is wife is.....Clara Wu Tsai -works closely with the Stanford University Neurosciences Institute and happens to be the advisory board for Institute for Protein Design. In August 2020, in the wake of the George Floyd protests, Wu Tsai and her husband donated $50 million to social justice and economic equality initiatives which support Black, Indigenous, and People of Color. The couple developed a five-point action plan and stated that they planned to focus on organizations in Brooklyn, New York. The Joe and Clara Tsai Foundation also donated to the University of California San Diego’s 21st Century China Center to expand its data-based research, policy engagement, and education on issues related to U.S.-China relations. Wu Tsai has a residence in La Jolla, California. https://marketrealist.com/p/joseph-tsai-political-views/ https://en.wikipedia.org/wiki/Clara_Wu_Tsai https://en.wikipedia.org/wiki/Joseph_Tsai
@Amy31129057 - QuestionIt
The Universal Influenza Vaccine. @RandPaul @SenRonJohnson @RepThomasMassie At UW in Washington State no less~😏What would it be without Bill Gates-Back in April of 2019 Institute for Protein Design wins $45M in funding from TED’s Audacious Project- The five-year grant adds to funding that the institute receives from the likes of the Bill & Melinda Gates Foundation and the National Institutes of Health. Right now, the institute has about 100 people on its staff, “and we are going to be ramping that number up considerably,” Baker said. That fits right in with the mission of The Audacious Project, which was launched by TED’s organizers with support from The Bridgespan Group. The project pulls together philanthropic funds from a variety of contributors — including the Skoll Foundation, Virgin Unite and the Dalio Foundation — and distributes the money to boost bold ideas. (https://finance.yahoo.com/news/institute-protein-design-wins-45m-000003695.html) Advisory Board- Bryan White- was Co-founder and Chief Investment Officer of Quadra/Quellos and subsequently BlackRock. George Church, is a professor of genetics at Harvard Medical School and director of http://PersonalGenomes.org, which provides the world’s only open-access information on human genomic, environmental, and trait data. Robert M. Hershberg-is a Venture Partner with Frazier Life Sciences and was was the President and CEO of VentiRx Pharmaceuticals, a clinical-stage biopharmaceutical company, which he co-founded in 2006. Jeff Wilke-retired as Amazon’s CEO Worldwide Consumer in February 2021. During his more than 21 years as a corporate officer, he led Amazon’s retail and third-party stores, operations, marketing, Prime, and technology teams. Clara Wu Tsai-works closely with the Stanford University Neurosciences Institute https://www.ipd.uw.edu/ https://www.ipd.uw.edu/people/advisory-board/ https://www.ipd.uw.edu/people/faculty_and_staff/ https://x.com/UWproteindesign/status/1398301974798299138?s=20 https://newsroom.uw.edu/news/institute-protein-design-holds-ai-safety-summit https://finance.yahoo.com/news/institute-protein-design-wins-45m-000003695.html
